

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Brexanolone, a neurosteroid antidepressant,... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/8-751/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/8-751" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Brexanolone, a neurosteroid antidepressant, vindicates the GABAergic deficit hypothesis of depression and may foster resilience" />
    
            <meta name="og:title" content="F1000Research Article: Brexanolone, a neurosteroid antidepressant, vindicates the GABAergic deficit hypothesis of depression and may foster resilience.">
            <meta name="og:description" content="Read the latest article version by Bernhard L&uuml;scher, Hanns M&ouml;hler, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="20548">
            <meta name="article-id" content="18758">
            <meta name="dc.title" content="Brexanolone, a neurosteroid antidepressant, vindicates the GABAergic deficit hypothesis of depression and may foster resilience">
            <meta name="dc.description" content="The GABAergic deficit hypothesis of depression states that a deficit of GABAergic transmission in defined neural circuits is causal for depression. Conversely, an enhancement of GABA transmission, including that triggered by selective serotonin reuptake inhibitors or ketamine, has antidepressant effects. Brexanolone, an intravenous formulation of the endogenous neurosteroid allopregnanolone, showed clinically significant antidepressant activity in postpartum depression. By allosterically enhancing GABA A receptor function, the antidepressant activity of allopregnanolone is attributed to an increase in GABAergic inhibition. In addition, allopregnanolone may stabilize normal mood by decreasing the activity of stress-responsive dentate granule cells and thereby sustain resilience behavior. Therefore, allopregnanolone may augment and extend its antidepressant activity by fostering resilience. The recent structural resolution of the neurosteroid binding domain of GABA A receptors will expedite the development of more selective ligands as a potential new class of central nervous system drugs.">
            <meta name="dc.subject" content="Major depressive disorder, anxiety, postpartum depression, rapid acting antidepressant, allopregnanolone, neurosteroid, GABA receptor ">
            <meta name="dc.creator" content="L&uuml;scher, Bernhard">
            <meta name="dc.creator" content="M&ouml;hler, Hanns">
            <meta name="dc.date" content="2019/05/29">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.18758.1">
            <meta name="dc.source" content="F1000Research 2019 8:751">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="Major depressive disorder">
            <meta name="prism.keyword" content="anxiety">
            <meta name="prism.keyword" content="postpartum depression">
            <meta name="prism.keyword" content="rapid acting antidepressant">
            <meta name="prism.keyword" content="allopregnanolone">
            <meta name="prism.keyword" content="neurosteroid">
            <meta name="prism.keyword" content="GABA receptor ">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2019/05/29">
            <meta name="prism.volume" content="8">
            <meta name="prism.number" content="751">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.18758.1">
            <meta name="prism.url" content="https://f1000research.com/articles/8-751">
            <meta name="citation_title" content="Brexanolone, a neurosteroid antidepressant, vindicates the GABAergic deficit hypothesis of depression and may foster resilience">
            <meta name="citation_abstract" content="The GABAergic deficit hypothesis of depression states that a deficit of GABAergic transmission in defined neural circuits is causal for depression. Conversely, an enhancement of GABA transmission, including that triggered by selective serotonin reuptake inhibitors or ketamine, has antidepressant effects. Brexanolone, an intravenous formulation of the endogenous neurosteroid allopregnanolone, showed clinically significant antidepressant activity in postpartum depression. By allosterically enhancing GABA A receptor function, the antidepressant activity of allopregnanolone is attributed to an increase in GABAergic inhibition. In addition, allopregnanolone may stabilize normal mood by decreasing the activity of stress-responsive dentate granule cells and thereby sustain resilience behavior. Therefore, allopregnanolone may augment and extend its antidepressant activity by fostering resilience. The recent structural resolution of the neurosteroid binding domain of GABA A receptors will expedite the development of more selective ligands as a potential new class of central nervous system drugs.">
            <meta name="citation_description" content="The GABAergic deficit hypothesis of depression states that a deficit of GABAergic transmission in defined neural circuits is causal for depression. Conversely, an enhancement of GABA transmission, including that triggered by selective serotonin reuptake inhibitors or ketamine, has antidepressant effects. Brexanolone, an intravenous formulation of the endogenous neurosteroid allopregnanolone, showed clinically significant antidepressant activity in postpartum depression. By allosterically enhancing GABA A receptor function, the antidepressant activity of allopregnanolone is attributed to an increase in GABAergic inhibition. In addition, allopregnanolone may stabilize normal mood by decreasing the activity of stress-responsive dentate granule cells and thereby sustain resilience behavior. Therefore, allopregnanolone may augment and extend its antidepressant activity by fostering resilience. The recent structural resolution of the neurosteroid binding domain of GABA A receptors will expedite the development of more selective ligands as a potential new class of central nervous system drugs.">
            <meta name="citation_keywords" content="Major depressive disorder, anxiety, postpartum depression, rapid acting antidepressant, allopregnanolone, neurosteroid, GABA receptor ">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Bernhard L&uuml;scher">
            <meta name="citation_author_institution" content="Department of Biology and Department of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, PA, 16802, USA">
            <meta name="citation_author_institution" content="Center for Molecular Investigation of Neurological Disorders, The Huck Institutes for the Life Sciences, Pennsylvania State University, University Park, PA, 16802, USA">
            <meta name="citation_author" content="Hanns M&ouml;hler">
            <meta name="citation_author_institution" content="Institute of Pharmacology and Neuroscience Center, University of Zurich, Zurich, 8057, Switzerland">
            <meta name="citation_author_institution" content="Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH), Zurich, 8057, Switzerland">
            <meta name="citation_publication_date" content="2019/05/29">
            <meta name="citation_volume" content="8">
            <meta name="citation_publication_number" content="751">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.18758.1">
            <meta name="citation_firstpage" content="751">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/8-751/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/8-751.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=20548 /> <input type=hidden id=articleId name=articleId value=18758 /> <input type=hidden id=xmlUrl value="/articles/8-751/v1/xml"/> <input type=hidden id=xmlFileName value="-8-751-v1.xml"> <input type=hidden id=article_uuid value=85d9febb-7bad-4cc1-a9e0-d3af4e7e06f8 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Brexanolone, a neurosteroid antidepressant, vindicates the GABAergic deficit hypothesis of depression and may foster resilience"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.18758.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.18758.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/8-751"
  },
  "headline": "Brexanolone, a neurosteroid antidepressant, vindicates the GABAergic deficit hypothesis of depression and...",
  "datePublished": "2019-05-29T12:27:59",
  "dateModified": "2019-05-29T12:27:59",
  "author": [
    {
      "@type": "Person",
      "name": "Bernhard L&uuml;scher"
    },    {
      "@type": "Person",
      "name": "Hanns M&ouml;hler"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "The GABAergic deficit hypothesis of depression states that a deficit of GABAergic transmission in defined neural circuits is causal for depression. Conversely, an enhancement of GABA transmission, including that triggered by selective serotonin reuptake inhibitors or ketamine, has antidepressant effects. Brexanolone, an intravenous formulation of the endogenous neurosteroid allopregnanolone, showed clinically significant antidepressant activity in postpartum depression. By allosterically enhancing GABAA receptor function, the antidepressant activity of allopregnanolone is attributed to an increase in GABAergic inhibition. In addition, allopregnanolone may stabilize normal mood by decreasing the activity of stress-responsive dentate granule cells and thereby sustain resilience behavior. Therefore, allopregnanolone may augment and extend its antidepressant activity by fostering resilience. The recent structural resolution of the neurosteroid binding domain of GABAA receptors will expedite the development of more selective ligands as a potential new class of central nervous system drugs."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/8-751",
            "name": "Brexanolone, a neurosteroid antidepressant, vindicates the GABAergic..."
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Brexanolone, a neurosteroid antidepressant, vindicates the GABAergic... </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=20548 data-id=18758 data-downloads="" data-views="" data-scholar="10.12688/f1000research.18758.1" data-recommended="" data-doi="10.12688/f1000research.18758.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/8-751/v1/pdf?article_uuid=85d9febb-7bad-4cc1-a9e0-d3af4e7e06f8" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-18758-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-18758-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-18758-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Lüscher B and Möhler H. Brexanolone, a neurosteroid antidepressant, vindicates the GABAergic deficit hypothesis of depression and may foster resilience [version 1; peer review: 4 approved]</span>. <i>F1000Research</i> 2019, <b>8</b>(F1000 Faculty Rev):751 (<a class=new-orange href="https://doi.org/10.12688/f1000research.18758.1" target=_blank>https://doi.org/10.12688/f1000research.18758.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-18758-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=18758 id=track-article-signin-18758 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/18758?target=/articles/8-751">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=20548 /> <input name=articleId type=hidden value=18758 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Brexanolone, a neurosteroid antidepressant, vindicates the GABAergic deficit hypothesis of depression and may foster resilience</h1><span class=other-info> [version 1; peer review: 4 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class=""><a href="mailto:BXL25@psu.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Bernhard L&uuml;scher</span></a><a href="https://orcid.org/0000-0003-1375-1906" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-1375-1906</div><sup>1,2</sup>,&nbsp;</span><span class="">Hanns M&ouml;hler<sup>3,4</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class=""><a href="mailto:BXL25@psu.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Bernhard L&uuml;scher</span></a><a href="http://orcid.org/0000-0003-1375-1906" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-1375-1906</div><sup>1,2</sup>,&nbsp;</span><span class="">Hanns M&ouml;hler<sup>3,4</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 29 May 2019 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.18758.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Biology and Department of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, PA, 16802, USA<br/> <sup>2</sup> Center for Molecular Investigation of Neurological Disorders, The Huck Institutes for the Life Sciences, Pennsylvania State University, University Park, PA, 16802, USA<br/> <sup>3</sup> Institute of Pharmacology and Neuroscience Center, University of Zurich, Zurich, 8057, Switzerland<br/> <sup>4</sup> Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH), Zurich, 8057, Switzerland<br/> <p> <div class=margin-bottom> Bernhard L&uuml;scher <br/> <span>Roles: </span> Conceptualization, Project Administration, Supervision, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Hanns M&ouml;hler <br/> <span>Roles: </span> Conceptualization, Project Administration, Supervision, Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=51507-48925></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=51510-48924></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=51508-48927></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=16677-48926></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> The GABAergic deficit hypothesis of depression states that a deficit of GABAergic transmission in defined neural circuits is causal for depression. Conversely, an enhancement of GABA transmission, including that triggered by selective serotonin reuptake inhibitors or ketamine, has antidepressant effects. Brexanolone, an intravenous formulation of the endogenous neurosteroid allopregnanolone, showed clinically significant antidepressant activity in postpartum depression. By allosterically enhancing GABA<sub>A</sub> receptor function, the antidepressant activity of allopregnanolone is attributed to an increase in GABAergic inhibition. In addition, allopregnanolone may stabilize normal mood by decreasing the activity of stress-responsive dentate granule cells and thereby sustain resilience behavior. Therefore, allopregnanolone may augment and extend its antidepressant activity by fostering resilience. The recent structural resolution of the neurosteroid binding domain of GABA<sub>A</sub> receptors will expedite the development of more selective ligands as a potential new class of central nervous system drugs. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> Major depressive disorder, anxiety, postpartum depression, rapid acting antidepressant, allopregnanolone, neurosteroid, GABA receptor </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Bernhard L&uuml;scher (<a href="mailto:BXL25@psu.edu">BXL25@psu.edu</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Bernhard Lüscher </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> No competing interests were disclosed. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> Research in the laboratory of BL is supported by grant MH099851 from the National Institute of Mental Health. BL also consults for Lactocore, Inc. <br/> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2019 Lüscher B and Möhler H. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Lüscher B and Möhler H. Brexanolone, a neurosteroid antidepressant, vindicates the GABAergic deficit hypothesis of depression and may foster resilience [version 1; peer review: 4 approved]</span>. <i>F1000Research</i> 2019, <b>8</b>(F1000 Faculty Rev):751 (<a href="https://doi.org/10.12688/f1000research.18758.1" target=_blank>https://doi.org/10.12688/f1000research.18758.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 29 May 2019, <b>8</b>(F1000 Faculty Rev):751 (<a href="https://doi.org/10.12688/f1000research.18758.1" target=_blank>https://doi.org/10.12688/f1000research.18758.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 29 May 2019, <b>8</b>(F1000 Faculty Rev):751 (<a href="https://doi.org/10.12688/f1000research.18758.1" target=_blank>https://doi.org/10.12688/f1000research.18758.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d4383e186>Introduction</h2><p class="" id=d4383e189>Major depressive disorder (MDD) represents the most common cause of total psychophysiological disability with a worldwide lifetime prevalence of 12 to 20% and estimated annual costs to the US economy of more than $100 billion<sup><a href="#ref-1">1</a>–<a href="#ref-3">3</a></sup>. MDD is difficult to treat, in part because it is a phenotypically and etiologically heterogeneous syndrome<sup><a href="#ref-4">4</a></sup>. Accordingly, it is challenging to conceive of a single mechanism that could account for most forms of this disease and of a treatment that might alleviate symptoms in the majority of patients. Indeed, current first-line antidepressants that are designed to modulate monoaminergic transmitter systems separate from placebo in only about 50% of clinical trials<sup><a href="#ref-5">5</a></sup>, are effective in fewer than two thirds of patients subjected to one or two regimens of treatment<sup><a href="#ref-6">6</a></sup>, and act with a delay of several weeks to months<sup><a href="#ref-7">7</a></sup>. Even among patients who respond to these treatments, only a small fraction show remission. These features often lead to endless and futile pursuits of an effective treatment and illustrate the enormous unmet need for better antidepressant therapies. Here, we summarize the GABAergic deficit hypothesis of depression and its clinical support by the neurosteroid brexanolone, which largely acts by enhancing GABAergic inhibition.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d4383e218>The GABAergic deficit hypothesis of depression</h2><p class="" id=d4383e221>The GABAergic deficit hypothesis of MDD posits that diverse defects in GABAergic neural inhibition can causally contribute to common phenotypes of MDD and conversely that the efficacy of current and future antidepressant therapies depends on their ability to restore GABAergic neurotransmission<sup><a href="#ref-8">8</a>,<a href="#ref-9">9</a></sup>. Consistent with this hypothesis, clinical studies over the past 15 years have provided compelling evidence that MDD is associated with diverse defects in GABAergic neurotransmission. This includes well-replicated findings of reduced brain levels of GABA<sup><a href="#ref-10">10</a>–<a href="#ref-12">12</a></sup>, reduced expression of glutamic acid decarboxylase (GAD) as the principal enzyme responsible for GABA synthesis by GABAergic interneurons<sup><a href="#ref-13">13</a>,<a href="#ref-14">14</a></sup>, reduced density or function of GABAergic interneurons<sup><a href="#ref-15">15</a>–<a href="#ref-17">17</a></sup>, and reduced expression and function of the principal receptors for GABA known as GABA<sub>A</sub> receptors<sup><a href="#ref-18">18</a>–<a href="#ref-20">20</a></sup>. Together, these changes explain the marked <i>functional</i> defects in cortical GABAergic inhibition observed in patients with MDD<sup><a href="#ref-21">21</a></sup>.</p><p class="" id=d4383e270>Beyond MDD, GABAergic deficits are also broadly implicated in anxiety disorders, which are highly comorbid with MDD<sup><a href="#ref-22">22</a></sup> but may have distinct developmental origins<sup><a href="#ref-23">23</a></sup>. Compared with other neuropsychiatric disorders, MDD shows low heritability of about 38%<sup><a href="#ref-24">24</a></sup>. Even this low heritability remains unexplained as attempts to replicate the identification of candidate genes of MDD have been failing<sup><a href="#ref-25">25</a>,<a href="#ref-26">26</a></sup>. Therefore, rather than relying on genetic models to explore disease mechanism, pre-clinical models of MDD are often based on the notion that chronic stress represents a major environmental vulnerability and precipitating factor of MDD. Consistent with a causative role of stress for MDD, chronic exposure of rodents to stress results in diverse behavioral alterations in a direction opposite to those induced by antidepressant drug treatment, and antidepressant drug treatments prevent or ameliorate the detrimental effects of stress in these models<sup><a href="#ref-27">27</a>,<a href="#ref-28">28</a></sup>. Chronic stress also results in reduced production and survival of adult-born hippocampal granule cell neurons and these cells are essential for at least some of the behavioral actions of antidepressants<sup><a href="#ref-29">29</a></sup>. Importantly, stress-induced behavioral alterations of rodents are associated with impairment of GABAergic interneurons, reduced expression of GAD and of the vesicular and plasma membrane transporters for GABA, and reduced density and function of GABAergic synapses<sup><a href="#ref-30">30</a>–<a href="#ref-34">34</a></sup>. In addition, chronic stress leads to marked deficits in the synthesis of endogenous GABA-potentiating neurosteroids, as detailed below. Lastly, chronic stress also leads to a shift in the chloride reversal potential to more depolarized membrane potentials, which renders GABAergic inhibition ineffective<sup><a href="#ref-35">35</a>,<a href="#ref-36">36</a></sup>. In corticotropin-releasing hormone (CRH) neurons of the hypothalamus, corresponding stress-induced loss of inhibitory drive leads to chronic hypothalamic–pituitary–adrenal (HPA) axis activation<sup><a href="#ref-35">35</a></sup>. Thus, stress-induced defects in GABAergic inhibition are self-perpetuating because they exacerbate stress-induced glutamate release and lead to chronically dysregulated stress axis function. Conversely, mechanisms that enhance GABAergic inhibition are predicted to confer stress resilience, a process that has been described by the American Psychological Association as “adapting well in the face of adversity, trauma, tragedy threats or significant sources of stress” (American Psychological Association, <a target=xrefwindow href="www.apa.org/helpcenter/road-resilience" id=d4383e321>www.apa.org/helpcenter/road-resilience</a>, last checked April 25, 2019).</p><p class="" id=d4383e325>Some of the most compelling evidence that defects in GABA transmission can <i>causally</i> contribute to stress-induced anxiety- and depressive-like symptoms is available from analyses of GABA<sub>A</sub> receptor mutant mice. Knockout mice that were rendered heterozygous for the γ2 subunit (γ2<sup>+/−</sup> mice, lacking one of 38 gene alleles that contribute to heteropentameric GABA<sub>A</sub> receptors) exhibit anxiety- and depression-related behavior, defects in hippocampal neurogenesis, cognitive deficits in emotional pattern separation, and chronic HPA axis activation that are expected of an animal model of MDD<sup><a href="#ref-23">23</a>,<a href="#ref-37">37</a>–<a href="#ref-40">40</a></sup>. Some of these same behavioral defects have been described in mice lacking the α2 subunit of GABA<sub>A</sub> receptors<sup><a href="#ref-41">41</a></sup> or the neurosteroid binding site of α2 GABA<sub>A</sub> receptors<sup><a href="#ref-42">42</a></sup> and in mice with genetically reduced GABA synthesis<sup><a href="#ref-43">43</a></sup>.</p><p class="" id=d4383e369>Chronic stress and defects in GABAergic transmission of γ2<sup>+/−</sup> mice further have in common that they result in similar homeostatic-like downregulation of ionotropic glutamate receptors (AMPA and NMDA receptors) and glutamatergic synaptic transmission (<a href="#f1">Figure 1</a>)<sup><a href="#ref-44">44</a>–<a href="#ref-46">46</a></sup>. The anxious and depression-related behavior and the functional defects in GABAergic and glutamatergic synaptic transmission of γ2<sup>+/−</sup> mice can be reversed for a prolonged period with the rapid-acting antidepressant ketamine<sup><a href="#ref-46">46</a></sup> (see below). Such defects in functional neural connectivity and their rescue by antidepressant therapies represent functional hallmarks of MDD<sup><a href="#ref-47">47</a>,<a href="#ref-48">48</a></sup>. Importantly, chronic treatment of γ2<sup>+/−</sup> mice with the norepinephrine (NE) reuptake inhibitor desipramine is able to similarly normalize the behavior of γ2<sup>+/−</sup> mice along with normalization of HPA axis function in these mice<sup><a href="#ref-40">40</a></sup>. Chronic stress–induced or optogenetic activation of NE neurons of the locus coerulus (LC) that project to dopaminergic (DA) neurons in the ventral tegmental area (VTA) mediates resilience to chronic social defeat stress of mice<sup><a href="#ref-49">49</a></sup>. In the VTA, LC-derived NE acts through α1- and β3-adrenergic receptors to induce homeostatic alterations of ion channel expression in DA neurons that contribute to stress resilience. Accordingly, we speculate that hyperexcitability of LC NE neurons in γ2<sup>+/−</sup> mice facilitates the antidepressant action of NE reuptake inhibitors to induce slow homeostatic changes in DA neurons that underlie stress resilience. Thus, both conventional antidepressants and ketamine can act to overcome genetic (that is, hard-wired) defects in GABAergic synaptic transmission, albeit by entirely different mechanisms. Moreover, directly and deliberately increasing the excitability of certain subsets of GABAergic interneurons in mice has robust anxiolytic and antidepressant-like behavioral and biochemical consequences<sup><a href="#ref-50">50</a></sup>. Collectively, these findings lend strong support to the GABAergic deficit hypothesis of MDD and suggest that certain (but not all) agents that enhance GABAergic inhibition may have antidepressant properties<sup><a href="#ref-8">8</a>,<a href="#ref-9">9</a></sup>. For example, benzodiazepines, which act as positive allosteric modulators of GABA<sub>A</sub> receptors and are first-line treatments for anxiety disorders, have only limited efficacy as antidepressants<sup><a href="#ref-51">51</a></sup>, even though they are often used to augment conventional antidepressants and to treat comorbidities of MDD, such as anxiety and insomnia<sup><a href="#ref-52">52</a>–<a href="#ref-55">55</a></sup>. Limited antidepressant efficacy of benzodiazepines may be due to tolerance, which is thought to involve chronic drug-induced degradation of major subsets of GABA<sub>A</sub> receptors and corresponding loss of inhibitory synapses<sup><a href="#ref-56">56</a>,<a href="#ref-57">57</a></sup>. However, two negative allosteric modulators of α5-GABA<sub>A</sub> receptors—L-655,708 and MRK-016—have been shown to exhibit rapid antidepressant-like activity in a chronic stress model of rodents<sup><a href="#ref-44">44</a>,<a href="#ref-58">58</a></sup>. Notably, in contrast to benzodiazepines and comparable to ketamine (discussed in the following), these agents act by transient disinhibition of neural circuits, which results in antidepressant-like activity in the “drug-off” situation.</p><a name=f1 class=n-a></a><div class="fig panel clearfix"><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/20548/c513940e-f18f-4e66-8335-d29006bfe361_figure1.gif"><img alt="c513940e-f18f-4e66-8335-d29006bfe361_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/20548/c513940e-f18f-4e66-8335-d29006bfe361_figure1.gif"></a><div class=caption><h3>Figure 1. Schematic of chronic stress and GABAergic deficit-induced downregulation of glutamatergic transmission and recovery by allopregnanolone.</h3><p id=d4383e475>HPA, hypothalamic–pituitary–adrenal; MDD, major depressive disorder.</p></div></div><p class="" id=d4383e482>The antidepressant mechanism of ketamine is unique in that it is very rapid and has the clinical benefits observed in the “drug-off” situation following a single acute dose of the drug. Recent progress in understanding of its mechanism has been thoroughly reviewed elsewhere<sup><a href="#ref-59">59</a>,<a href="#ref-60">60</a></sup> and is only briefly recapitulated here. Key aspects of the antidepressant mechanism of ketamine are that it involves brief inhibition of GABAergic interneurons<sup><a href="#ref-61">61</a></sup> followed by a transient surge in glutamate release<sup><a href="#ref-62">62</a></sup> (lasting at most 1 hour) that then triggers the release of brain-derived neurotrophic factor (BDNF)<sup><a href="#ref-63">63</a></sup> and a wave of synaptogenesis<sup><a href="#ref-64">64</a></sup>. The ensuing increase in synapse density, the corresponding restoration of neural connectivity, and normalized emotional behavior are all observed in the drug-off state and last for several days. Notably, ketamine-induced synaptogenesis and antidepressant behavioral response are drastically enhanced by GABAergic deficits, as observed in γ2<sup>+/−</sup> mice<sup><a href="#ref-46">46</a></sup> and also evident in animals exposed to chronic stress<sup><a href="#ref-65">65</a>,<a href="#ref-66">66</a></sup>, perhaps because neural hyperexcitability in these models facilitates the ketamine-induced glutamate surge and BDNF release. Importantly, restoration of glutamatergic synapses in γ2<sup>+/−</sup> mice is associated with even more dramatic formation and pre- and post-synaptic potentiation of GABAergic synapses<sup><a href="#ref-46">46</a></sup>, which appears to ensure that inhibitory and excitatory synaptic transmission remain balanced. Indeed, we found no evidence in the literature that ketamine treatment triggers seizures, despite the glutamate surge and evidence of a reduced seizure threshold in patients with MDD<sup><a href="#ref-67">67</a></sup>. Similar to restoration of glutamatergic synapses, ketamine-induced strengthening of GABAergic synapses is long-lasting and observed in the drug-off situation<sup><a href="#ref-46">46</a></sup> and temporally separated from the initial direct action of ketamine at GABAergic interneurons mentioned above. Here, we propose that <i>direct</i> and potent pharmacological enhancement of GABAergic transmission (that is, by allopregnanolone) will act accordingly to transiently dampen glutamate release and allow for lasting recovery of glutamatergic and GABAergic synaptic transmission beyond the end of treatment (<a href="#f1">Figure 1</a>).</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d4383e548>Neurosteroids differentially modulate phasic and tonic GABAergic inhibition</h2><p class="" id=d4383e551>Neurosteroids are metabolites of cholesterol-derived steroid hormones synthesized in the brain by neurons and astrocytes. They act as potent, endogenous, positive allosteric modulators of GABA<sub>A</sub> receptors and include derivatives of progesterone and deoxycorticosterone, in particular 3a,5a-tetrahydroprogesterone (3α,5α-THP; allopregnanolone), 3α,5β-tetrahydro-progesterone (3α,5β-THP; pregnanolone), and 3α,5α tetrahydrodeoxycorticosterone (3α,5α-THDOC; allotetrahydro-deoxycorticosterone).</p><p class="" id=d4383e557>Neurosteroids such as allopregnanolone have little effect on the rise time or the amplitude of GABA-induced synaptic currents but primarily prolong the decay kinetics of the GABA-gated ion channel<sup><a href="#ref-68">68</a></sup>, which results in an increase of the mean channel open time of the GABA-activated chloride channel and a prolonged inhibitory post-synaptic current. However, when acting on extra-synaptic receptors that are kept tonically active by ambient concentrations of GABA, the allopregnanolone-induced prolonged decay kinetic results in an increased amplitude of the tonic current. In addition to potentiation of GABA<sub>A</sub> receptor channel function<sup><a href="#ref-69">69</a>,<a href="#ref-70">70</a></sup>, allopregnanolone and its synthetic derivatives may potentiate GABA transmission by promoting the cell surface expression of GABA<sub>A</sub> receptors<sup><a href="#ref-71">71</a></sup>. The impact on phasic or tonic inhibition can be strikingly different because of the type of GABA<sub>A</sub> receptor subtype involved. The prototypic synaptic receptor contains α1, β2/3, and γ2 subunits and is sensitive to physiological concentrations of neurosteroids<sup><a href="#ref-68">68</a></sup>. However, in certain cells, such as dentate gyrus (DG) granule cells or cerebellar granule cells, allopregnanolone at low concentrations (10–100 nM) selectively enhances tonic inhibition with little or no effect on phasic conductance. This appears to be due largely to the preponderance of highly neurosteroid-sensitive extra-synaptic δ subunit–containing receptors with the subunit combinations α4,β3,δ, and α6,β2,3,δ<sup><a href="#ref-72">72</a>–<a href="#ref-74">74</a></sup>. In addition, phosphorylation of the β3 subunit by protein kinase C appears to promote neurosteroid sensitivity of extra-synaptic receptors while limiting that of synaptic receptors<sup><a href="#ref-75">75</a></sup>. In some neurons, the strict division of GABA<sub>A</sub> receptors into synaptic and extra-synaptic receptors mediating phasic and tonic inhibition, respectively, has become an oversimplification<sup><a href="#ref-76">76</a></sup>. The therapeutic action of brexanolone (peak steady-state plasma concentration of about 150 nM; see below) is likely to comprise an enhancement of both phasic and tonic inhibition.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d4383e610>Downregulation of neurosteroids in affective disorders</h2><p class="" id=d4383e613>The downregulation of neurosteroid biosynthesis has been implicated as a possible contributor to various psychiatric conditions, as shown in a number of clinical trials. In patients with MDD, allopregnanolone and pregnanolone were decreased in cerebrospinal fluid (CSF)<sup><a href="#ref-77">77</a></sup> and in plasma<sup><a href="#ref-78">78</a>,<a href="#ref-79">79</a></sup>. Plasma allopregnanolone was similarly decreased in postpartum “blues”<sup><a href="#ref-80">80</a></sup> (but see below), post-traumatic stress disorder<sup><a href="#ref-81">81</a>,<a href="#ref-82">82</a></sup>, schizophrenia negative symptomatology<sup><a href="#ref-83">83</a></sup>, pain<sup><a href="#ref-84">84</a></sup>, and pharmacologically induced panic attacks<sup><a href="#ref-85">85</a></sup> but did not reach significance in general anxiety disorder<sup><a href="#ref-86">86</a></sup>. Conversely, the 3β isomer of allopregnanolone antagonizes GABA<sub>A</sub> receptor function<sup><a href="#ref-87">87</a></sup> and is increased in panic attacks<sup><a href="#ref-88">88</a></sup>. Based on studies of postmortem brain, changes in the neurosteroid synthesis pathways were also proposed to contribute to the pathologies of neurodegenerative and inflammatory diseases (Alzheimer’s and Parkinson’s disease and multiple sclerosis)<sup><a href="#ref-89">89</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d4383e674>Stress-induced behavior linked to downregulation of neurosteroids</h2><p class="" id=d4383e677>Because chronic stress is a major risk factor for depression, the influence of chronic stress on neurosteroids has become a major focus. In striking contrast to acute stress, which increases allopregnanolone levels<sup><a href="#ref-89">89</a>,<a href="#ref-90">90</a></sup>, chronic stress and pharmacological induction of panic attacks<sup><a href="#ref-84">84</a></sup> result in reduced levels of neurosteroids. In animal models of chronic stress, the concentration of allopregnanolone was decreased in serum<sup><a href="#ref-91">91</a>–<a href="#ref-93">93</a></sup> and in selected corticolimbic brain areas<sup><a href="#ref-94">94</a></sup>. This decrease was attributed to stress-induced downregulation of the 5α-hydroxysteroid-dehydrogenase, the rate-limiting enzyme in the synthesis of allopregnanolone<sup><a href="#ref-92">92</a>,<a href="#ref-95">95</a>,<a href="#ref-96">96</a></sup>. Moreover, the stress-induced reduction of allopregnanolone was associated with heightened depressive/anxiety-like behavioral phenotypes, increased fear and aggression behavior, dysregulation of the HPA axis<sup><a href="#ref-92">92</a>,<a href="#ref-94">94</a>,<a href="#ref-97">97</a></sup>, and impaired adult hippocampal neurogenesis<sup><a href="#ref-98">98</a>,<a href="#ref-99">99</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d4383e734>Allopregnanolone ameliorates anxiety- and depression-related behavior</h2><p class="" id=d4383e737>Administration of allopregnanolone either before or after a period of chronic stress was able to alleviate the symptoms of depressive/anxiety behavior, prevent or normalize HPA axis dysfunction, and restore neurogenesis and cognitive deficits in transgenic mouse models of Alzheimer’s disease<sup><a href="#ref-99">99</a>–<a href="#ref-101">101</a></sup>. Furthermore, allopregnanolone and pregnanolone produced anxiolytic-like effects in various animal models of anxiety<sup><a href="#ref-102">102</a></sup>. Micro-infusion of allopregnanolone identified the amygdala as being relevant for anxiolysis<sup><a href="#ref-103">103</a></sup> and both the hippocampus and amygdala for overcoming learned helplessness<sup><a href="#ref-104">104</a></sup>. These results support a role of allopregnanolone in ameliorating symptoms of depression and anxiety and thereby support the view that a pathological deficit of GABAergic transmission contributes to these disorders<sup><a href="#ref-8">8</a>,<a href="#ref-9">9</a>,<a href="#ref-105">105</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d4383e772>Classic antidepressants normalize neurosteroid levels in depression</h2><p class="" id=d4383e775>With allopregnanolone being able to overcome depressive-like behavior, the question arose whether classic antidepressant drugs would act via an enhancement of neurosteroid levels. In animal models of depression, multiple antidepressants (fluoxetine, fluvoxamine, sertraline, desipramine, venlafaxine, and paroxetine) normalized corticolimbic levels of allopregnanolone concomitant with reduced anxiety-like, fear, and aggression behavior<sup><a href="#ref-83">83</a>,<a href="#ref-92">92</a>,<a href="#ref-106">106</a>,<a href="#ref-107">107</a></sup>. This effect, as shown for selective serotonin reuptake inhibitors (SSRIs), was independent of their ability to inhibit serotonin reuptake<sup><a href="#ref-108">108</a>–<a href="#ref-110">110</a></sup> and in the case of fluoxetine is thought to involve inhibition of a microsomal dehydrogenase that oxidizes allopregnanolone to 5α-dihydroprogesterone<sup><a href="#ref-111">111</a></sup>.</p><p class="" id=d4383e802>These findings gave reason to test whether the clinical effectiveness of SSRIs was linked to normalizing the allopregnanolone level. Indeed, in patients with unipolar depression, the decreased allopregnanolone level, measured in CSF, was normalized after 8 to 10 weeks of treatment with fluoxetine or fluvoxamine and correlated with an improved symptomatology<sup><a href="#ref-77">77</a></sup>. This finding was extended to a range of antidepressants (SSRIs and tricyclic antidepressants), which normalized plasma allopregnanolone levels concomitant with an improvement of depression<sup><a href="#ref-109">109</a></sup>. A normalization of plasma allopregnanolone and pregnenolone was also seen following 3 weeks of mirtazapine treatment in patients with major depression<sup><a href="#ref-79">79</a></sup>. Notably, the mirtazapine-induced maximal increases in these neurosteroids preceded their maximal clinical effects by about 2 weeks, suggesting that they are part of the pharmacological response mechanism rather than a subsequent measure of clinical improvement. These pre-clinical and clinical findings support the view that the neurosteroidogenic action of SSRIs may constitute a major part of their therapeutic effectiveness in patients with depressive disorders.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d4383e820>Postpartum risk of depression</h2><p class="" id=d4383e823>Postpartum depression (PPD) is an important public health issue as it affects women at a highly vulnerable time and can affect the cognitive and emotional development of the child<sup><a href="#ref-112">112</a></sup>. The risk of depression in women becomes significantly increased during the postpartum period, and nearly 20% of mothers have PPD, which is frequently preceded by antenatal anxiety- and depression-related symptoms or chronic stress as the strongest predictors<sup><a href="#ref-113">113</a>–<a href="#ref-115">115</a></sup>. PPD is frequently attributed to a maladaptation to peripartum fluctuations in reproductive hormone levels during pregnancy and the postpartum period<sup><a href="#ref-116">116</a>,<a href="#ref-117">117</a></sup>. Plasma allopregnanolone concentrations rise in parallel with progesterone throughout pregnancy, reaching the highest level in the third trimester and decreasing abruptly after childbirth<sup><a href="#ref-80">80</a></sup>.</p><p class="" id=d4383e848>Nevertheless, peripartum changes in gonadal hormones affect the emotional brain in vulnerable women. PPD was characterized by abnormal activation of the same brain regions implicated in non-puerperal major depression<sup><a href="#ref-118">118</a></sup>. The resting-state functional connectivity within corticolimbic regions implicated in depression was attenuated compared with healthy postpartum women<sup><a href="#ref-114">114</a></sup>. Similarly, emotionally normal (euthymic) women with a history of PPD showed stronger signs of depression than controls in tests of withdrawal from supra-physiological gonadal steroid levels<sup><a href="#ref-119">119</a></sup>. Additional factors that have been implicated in the pathophysiology of PPD include the lactogenic hormones oxytocin and prolactin, thyroid function, and a hyperactivity of the HPA axis<sup><a href="#ref-117">117</a></sup>. As outlined below, the potential importance of GABA<sub>A</sub> receptor plasticity in PPD has been derived largely from animal studies<sup><a href="#ref-120">120</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d4383e878>Animal models of postpartum depression and GABAergic impact</h2><p class="" id=d4383e881>Rodent models suggest that both phasic and tonic GABAergic inhibition in the brain are decreased during pregnancy in parallel with a decrease in GABA<sub>A</sub> receptor expression as shown for the GABA<sub>A</sub> receptor γ2 and δ subunit in mouse and rat hippocampus<sup><a href="#ref-121">121</a></sup>. Within days after parturition, GABAergic transmission and the level of GABA<sub>A</sub> receptor expression rebound to control levels<sup><a href="#ref-121">121</a>,<a href="#ref-122">122</a></sup>. This fluctuation in receptor expression is considered to be a homeostatic response to the elevated levels of pregnenolone and allopregnanolone in plasma and brain during rodent pregnancy and their rapid return to control levels postpartum<sup><a href="#ref-122">122</a>,<a href="#ref-123">123</a></sup>.</p><p class="" id=d4383e912>A transgenic animal model of PPD supports the view that the pathophysiology of PPD may be related to a deficit of GABA<sub>A</sub> receptor plasticity. Mice that lacked the GABA<sub>A</sub> receptor δ subunit partly or fully (<i>Gabrd</i><sup>+/−</sup> and <i>Gabrd</i><sup>−/−</sup>) exhibited PPD-like behavior (reduced latency to immobility in the Porsolt forced swim test and reduced sucrose preference) and abnormal maternal behavior (reduced nesting behavior and pup care)<sup><a href="#ref-121">121</a></sup>. Remarkably, the mice were behaviorally unremarkable until an animal was exposed to pregnancy and the postpartum state. Thus, reproductive events unmask the genetic susceptibility to affective dysregulation. The abnormal postpartum behavior in <i>Gabrd</i><sup>+/−</sup> mice was ameliorated by THIP, a GABA analogue with preferential affinity to GABA<sub>A</sub> receptors containing the δ subunit<sup><a href="#ref-121">121</a></sup> and the neuroactive steroid SGE-516<sup><a href="#ref-115">115</a></sup>.</p><p class="" id=d4383e952>Another animal model suggests that the dysregulation of the HPA axis is sufficient to induce abnormal postpartum behavior<sup><a href="#ref-115">115</a></sup>. CRH neurons in the paraventricular nucleus (PVN) of the hypothalamus govern the HPA axis and are critical for mounting the physiological response to stress. Chemogenetic activation of CRH neurons in the PVN was sufficient to induce abnormal postpartum behavior. Similarly, when GABAergic currents were reduced selectively in CRH neurons (KCC2/Crh mice), a depression-related phenotype and a deficit in maternal behavior were apparent in the postpartum period. In wild-type mice, the stress-induced activation of the HPA axis and the corresponding elevation of circulating corticosterone are normally blunted during pregnancy and postpartum<sup><a href="#ref-124">124</a></sup>. The inability to blunt this stress-induced HPA axis activation in this model is thought to contribute to PPD. The neuroactive steroid SGE-516 ameliorated the behavioral deficits caused by the dysregulation of the HPA axis<sup><a href="#ref-115">115</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d4383e970>Brexanolone in the treatment of postpartum depression</h2><p class="" id=d4383e973>In line with the evidence described above, brexanolone, an intravenous formulation of allopregnanolone, underwent clinical tests to treat PPD. In a double-blind, randomized, placebo-controlled phase II trial, female in-patients with PPD (n = 21) received a 60-hour continuous infusion of brexanolone at a dose of up to 60 μg/kg per hour or placebo. Women who received treatment, in comparison with those who received placebo, had a significant and clinically meaningful reduction in mean total score on the 17-item HAMILTON Rating Scale for Depression (HAM-D) at the 60-hour time point<sup><a href="#ref-125">125</a></sup>. In a subsequent phase III study with 246 patients, performed in two parts using the same design but two doses of drug, the HAM-D score was again significantly and clinically meaningfully decreased. The HAM-D total score mean reductions versus placebo were −5.5 and −3.7 points for the high and low dose, respectively (90 and 60 μg/kg per hour), and dizziness and somnolence were potential side effects<sup><a href="#ref-126">126</a></sup>. Notably, brexanolone is very rapidly cleared from plasma, which explains the need for continuous drug infusion<sup><a href="#ref-127">127</a></sup>. The higher dose explored above (90 μg/kg per hour) results in peak steady-state plasma concentrations of allopregnanolone (50 ng/mL) equivalent to those naturally reached in the third trimester of pregnancy<sup><a href="#ref-128">128</a></sup>. The antidepressant drug effect was shown to become significant within 48 hours of drug infusion for both doses. Moreover, the mean reduction in HAM-D total scores observed for the high-dose treatment at the end of the study (day 30) was similar in magnitude to that observed at the end of the 60-hour infusion. Thus, in the context of PPD, brexanolone showed a rapid mode of action that is reminiscent of that of ketamine in MDD and appears to result in durable clinical improvement (<a href="#f1">Figure 1</a>). Brexanolone was very recently approved for the treatment of PPD<sup><a href="#ref-129">129</a></sup>.</p><p class="" id=d4383e1000>Although a decrease in serum allopregnanolone (but not progesterone) was reported in one study in women with postpartum “blues”<sup><a href="#ref-80">80</a></sup>, there is no consistent evidence of abnormal basal circulating levels of allopregnanolone in PPD<sup><a href="#ref-114">114</a>,<a href="#ref-116">116</a>,<a href="#ref-117">117</a>,<a href="#ref-130">130</a></sup>. With allopregnanolone levels being normal, the antidepressant action of brexanolone is attributed to an enhancement of GABA<sub>A</sub> receptor function, thereby supporting the GABAergic deficit hypothesis of depression. In addition, emerging evidence suggests that allopregnanolone has anti-inflammatory effects <i>in vitro</i>, a property that could contribute to its antidepressant activity <i>in vivo</i><sup><a href="#ref-78">78</a></sup>. The antidepressant properties of brexanolone in PPD may be applicable to other forms of depression that are less clearly linked to altered neurosteroid physiology and that may be associated with defects in phasic rather than tonic GABAergic inhibition<sup><a href="#ref-113">113</a>,<a href="#ref-114">114</a>,<a href="#ref-118">118</a></sup>. Indeed, emerging evidence suggests that the anxiolytic effects of endogenous neurosteroids (even at their natural physiological concentrations) are mediated in part by α2 subunit–containing synaptic GABA<sub>A</sub> receptors<sup><a href="#ref-42">42</a></sup>. Moreover, a synthetic derivative of allopregnanolone (zuranolone, SAGE-217) is currently in phase 3 clinical development for PPD and MDD<sup><a href="#ref-131">131</a></sup>. Notably, potentiation of GABA transmission by brexanolone and potentially also zuranolone, unlike SSRIs that exhibit therapeutic delays of weeks or months, confers rapid and lasting antidepressant effects that are observed in the drug-off situation, reminiscent of mechanisms of ketamine. Interestingly, since allopregnanolone promotes proliferation of progenitor cells and restores neurogenesis in disease states<sup><a href="#ref-99">99</a>–<a href="#ref-101">101</a>,<a href="#ref-132">132</a></sup>, it may also support neurogenesis-dependent resilience behavior, as outlined below.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d4383e1067>Resilience due to changes in neural circuits</h2><p class="" id=d4383e1070>Studies of stress resilience have opened up a fundamentally new way of understanding an individual’s response to adverse life events such as trauma, tragedy, and chronic stress and its ability to avoid deleterious behavioral changes such as anxiety disorders, post-traumatic stress disorder, or depression. Although resilience, as defined in humans, is difficult to relate to animal studies, animal models are indispensable in the search for biological determinants of resilience (that is, protective changes that occur in resilient animals). This is all the more important as mechanisms that promote resilience to stress hold the promise of enabling the development of more efficacious antidepressant therapies.</p><p class="" id=d4383e1073>After chronic social defeat stress, about 40% of the stressed mice do not exhibit social avoidance or anhedonia in subsequent testing<sup><a href="#ref-133">133</a>,<a href="#ref-134">134</a></sup>. This is interpreted as resilience behavior and is associated with many distinct changes, particularly in the brain’s reward regions<sup><a href="#ref-133">133</a>–<a href="#ref-135">135</a></sup>. These changes include homeostatic adaptations of dopamine neurons in the VTA that prevent chronic stress–induced aberrant hyperexcitability of these cells<sup><a href="#ref-49">49</a>,<a href="#ref-136">136</a>,<a href="#ref-137">137</a></sup>, the induction of immediate early gene products in the medial prefrontal cortex (mPFC)<sup><a href="#ref-138">138</a></sup>, the sustainment of GABAergic inhibition and reduction of excitatory activity in the nucleus accumbens<sup><a href="#ref-139">139</a></sup>, the prevention of spine density loss in the mPFC and hippocampus<sup><a href="#ref-140">140</a></sup>, and epigenetic genomic changes that promote resilience in later life because of greater maternal care<sup><a href="#ref-141">141</a>,<a href="#ref-142">142</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d4383e1124>Adult neurogenesis linked to resilience via GABAergic inhibition</h2><p class="" id=d4383e1127>More recently, adult neurogenesis in the DG of the hippocampus has been implicated in conferring resilience to the detrimental depressive-like consequences of chronic stress exposure of mice<sup><a href="#ref-143">143</a></sup>. Chemogenetic inhibition of immature adult-born neurons in ventral DG (vDG) <i>in vivo</i> promoted susceptibility to social defeat stress. In contrast, increasing neurogenesis by inducible deletion of the proapoptotic gene <i>Bax</i> (iBax mice) selectively from adult neural progenitor cells conferred resilience to chronic stress as measured by the time spent socially interacting with a novel mouse and the time spent exploring the center in an open field. On the cellular level, a subset of mature DG cells was identified as stress-responsive cells that were active preferentially during attack (17% of cells on defeat day 1 to 34% of cells on defeat day 10). The activity of the stress-responsive mature cells was decreased when neurogenesis was increased. Thus, immature adult-born granule cells inhibit mature stress-responsive granule cells in the vDG, which protects the animals from chronic stress–induced depressive and anxiety-like consequences. The inhibition of mature granule cells by immature adult-born cells is likely to involve activation of hilar GABAergic interneurons that are known to confer a strong inhibitory influence on mature granule cells<sup><a href="#ref-144">144</a></sup>. Neurosteroids are predestined to inhibit DG granule cells because of their high level of expression of δ subunit–containing GABA<sub>A</sub> receptors, which are highly neurosteroid-sensitive<sup><a href="#ref-68">68</a>,<a href="#ref-72">72</a>–<a href="#ref-74">74</a></sup>.</p><p class="" id=d4383e1158>The finding that GABAergic interneuron activity can support resilience may give rise to a potential GABAergic hypothesis of resilience, which conceivably is independent of the prerequisite of adult neurogenesis. Decreased GABAergic interneuron activity would be expected to reduce resilience behavior whereas enhancing GABAergic transmission would sustain it. The neurosteroid allopregnanolone appears to be a case in point. Its clinical effectiveness as an antidepressant in treating PPD might be supported, at least in part, by its ability to foster resilience.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d4383e1164>Outlook</h2><p class="" id=d4383e1167>The demonstration of the clinical effectiveness of allopregnanolone in PPD lends new support to the GABAergic deficit hypothesis of MDD. This finding bodes well for further investigations of ligands for the neurosteroid site as a new class of drugs for affective disorders. To achieve this goal, a differentiation of GABA<sub>A</sub> receptors beyond that achieved by allopregnanolone is required. The recent molecular x-ray resolution of the neurosteroid binding domain is an essential step forward. In chimeric homopentameric GABA<sub>A</sub> receptor constructs, the neurosteroid THDOC was bound at the bottom of the transmembrane domain across each of the subunit interfaces<sup><a href="#ref-146">145</a>–<a href="#ref-147">147</a></sup> and similar findings are expected for heteropentameric GABA<sub>A</sub> receptors<sup><a href="#ref-145">145</a>,<a href="#ref-148">148</a></sup>. These studies provide a structural framework for the development of more selective ligands acting at the neurosteroid site for the treatment of affective disorders, including PPD and MDD, but also pain and epilepsy.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d4383e1 class=n-a></a><h2 class=main-title id=d4802>Grant information</h2><p>Research in the laboratory of BL is supported by grant MH099851 from the National Institute of Mental Health. BL also consults for Lactocore, Inc.</p><p> <i>The funders had no role in content selection, decision to publish, or any other aspects of preparation of the manuscript.</i> </p></div><div class=back-section><a name=d4383e1197 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d5322>References</h2><div class="section ref-list"><a name=d4383e1197 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d4383e1204 class=n-a></a>Kessler RC, Berglund P, Demler O, <i> et al.</i>: The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). <i>JAMA.</i> 2003; <b>289</b>(23): 3095–105. <a target=xrefwindow id=d4383e1215 href="http://www.ncbi.nlm.nih.gov/pubmed/12813115">PubMed Abstract </a> | <a target=xrefwindow id=d4383e1218 href="https://doi.org/10.1001/jama.289.23.3095">Publisher Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d4383e1227 class=n-a></a>Belmaker RH, Agam G: Major depressive disorder. <i>N Engl J Med.</i> 2008; <b>358</b>(1): 55–68. <a target=xrefwindow id=d4383e1235 href="http://www.ncbi.nlm.nih.gov/pubmed/18172175">PubMed Abstract </a> | <a target=xrefwindow id=d4383e1238 href="https://doi.org/10.1056/NEJMra073096">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d4383e1247 class=n-a></a>Milane MS, Suchard MA, Wong ML, <i> et al.</i>: Modeling of the temporal patterns of fluoxetine prescriptions and suicide rates in the United States. <i>PLoS Med.</i> 2006; <b>3</b>(6): e190. <a target=xrefwindow id=d4383e1258 href="http://www.ncbi.nlm.nih.gov/pubmed/16768544">PubMed Abstract </a> | <a target=xrefwindow id=d4383e1261 href="https://doi.org/10.1371/journal.pmed.0030190">Publisher Full Text </a> | <a target=xrefwindow id=d4383e1265 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1475655">Free Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d4383e1274 class=n-a></a>Kendler KS: The Phenomenology of Major Depression and the Representativeness and Nature of DSM Criteria. <i>Am J Psychiatry.</i> 2016; <b>173</b>(8): 771–80. <a target=xrefwindow id=d4383e1282 href="http://www.ncbi.nlm.nih.gov/pubmed/27138588">PubMed Abstract </a> | <a target=xrefwindow id=d4383e1285 href="https://doi.org/10.1176/appi.ajp.2016.15121509">Publisher Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d4383e1294 class=n-a></a>Khan A, Khan SR, Walens G, <i> et al.</i>: Frequency of positive studies among fixed and flexible dose antidepressant clinical trials: an analysis of the food and drug administration summary basis of approval reports. <i>Neuropsychopharmacology.</i> 2003; <b>28</b>(3): 552–7. <a target=xrefwindow id=d4383e1305 href="http://www.ncbi.nlm.nih.gov/pubmed/12629536">PubMed Abstract </a> | <a target=xrefwindow id=d4383e1308 href="https://doi.org/10.1038/sj.npp.1300059">Publisher Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d4383e1318 class=n-a></a>Rush AJ, Trivedi MH, Wisniewski SR, <i> et al.</i>: Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. <i>Am J Psychiatry.</i> 2006; <b>163</b>(11): 1905–17. <a target=xrefwindow id=d4383e1329 href="http://www.ncbi.nlm.nih.gov/pubmed/17074942">PubMed Abstract </a> | <a target=xrefwindow id=d4383e1332 href="https://doi.org/10.1176/ajp.2006.163.11.1905">Publisher Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d4383e1341 class=n-a></a>Insel TR, Wang PS: The STAR*D trial: revealing the need for better treatments. <i>Psychiatr Serv.</i> 2009; <b>60</b>(11): 1466–7. <a target=xrefwindow id=d4383e1349 href="http://www.ncbi.nlm.nih.gov/pubmed/19880463">PubMed Abstract </a> | <a target=xrefwindow id=d4383e1352 href="https://doi.org/10.1176/ps.2009.60.11.1466">Publisher Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d4383e1361 class=n-a></a>Luscher B, Shen Q, Sahir N: The GABAergic deficit hypothesis of major depressive disorder. <i>Mol Psychiatry.</i> 2011; <b>16</b>(4): 383–406. <a target=xrefwindow id=d4383e1369 href="http://www.ncbi.nlm.nih.gov/pubmed/21079608">PubMed Abstract </a> | <a target=xrefwindow id=d4383e1372 href="https://doi.org/10.1038/mp.2010.120">Publisher Full Text </a> | <a target=xrefwindow id=d4383e1375 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3412149">Free Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725441786"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4383e1384 class=n-a></a>Luscher B, Fuchs T: GABAergic control of depression-related brain states. <i>Adv Pharmacol.</i> 2015; <b>73</b>: 97–144. <a target=xrefwindow id=d4383e1392 href="http://www.ncbi.nlm.nih.gov/pubmed/25637439">PubMed Abstract </a> | <a target=xrefwindow id=d4383e1395 href="https://doi.org/10.1016/bs.apha.2014.11.003">Publisher Full Text </a> | <a target=xrefwindow id=d4383e1398 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4784429">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725441786">F1000 Recommendation</a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d4383e1411 class=n-a></a>Sanacora G, Gueorguieva R, Epperson CN, <i> et al.</i>: Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. <i>Arch Gen Psychiatry.</i> 2004; <b>61</b>(7): 705–13. <a target=xrefwindow id=d4383e1422 href="http://www.ncbi.nlm.nih.gov/pubmed/15237082">PubMed Abstract </a> | <a target=xrefwindow id=d4383e1425 href="https://doi.org/10.1001/archpsyc.61.7.705">Publisher Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d4383e1434 class=n-a></a>Hasler G, van der Veen JW, Tumonis T, <i> et al.</i>: Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. <i>Arch Gen Psychiatry.</i> 2007; <b>64</b>(2): 193–200. <a target=xrefwindow id=d4383e1445 href="http://www.ncbi.nlm.nih.gov/pubmed/17283286">PubMed Abstract </a> | <a target=xrefwindow id=d4383e1448 href="https://doi.org/10.1001/archpsyc.64.2.193">Publisher Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d4383e1458 class=n-a></a>Gabbay V, Mao X, Klein RG, <i> et al.</i>: Anterior cingulate cortex γ-aminobutyric acid in depressed adolescents: relationship to anhedonia. <i>Arch Gen Psychiatry.</i> 2012; <b>69</b>(2): 139–49. <a target=xrefwindow id=d4383e1469 href="http://www.ncbi.nlm.nih.gov/pubmed/21969419">PubMed Abstract </a> | <a target=xrefwindow id=d4383e1472 href="https://doi.org/10.1001/archgenpsychiatry.2011.131">Publisher Full Text </a> | <a target=xrefwindow id=d4383e1476 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3711232">Free Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d4383e1485 class=n-a></a>Karolewicz B, Maciag D, O'Dwyer G, <i> et al.</i>: Reduced level of glutamic acid decarboxylase-67 kDa in the prefrontal cortex in major depression. <i>Int J Neuropsychopharmacol.</i> 2010; <b>13</b>(4): 411–20. <a target=xrefwindow id=d4383e1496 href="http://www.ncbi.nlm.nih.gov/pubmed/20236554">PubMed Abstract </a> | <a target=xrefwindow id=d4383e1499 href="https://doi.org/10.1017/S1461145709990587">Publisher Full Text </a> | <a target=xrefwindow id=d4383e1503 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2857696">Free Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/13357243"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4383e1512 class=n-a></a>Guilloux JP, Douillard-Guilloux G, Kota R, <i> et al.</i>: Molecular evidence for BDNF- and GABA-related dysfunctions in the amygdala of female subjects with major depression. <i>Mol Psychiatry.</i> 2012; <b>17</b>(11): 1130–42. <a target=xrefwindow id=d4383e1523 href="http://www.ncbi.nlm.nih.gov/pubmed/21912391">PubMed Abstract </a> | <a target=xrefwindow id=d4383e1526 href="https://doi.org/10.1038/mp.2011.113">Publisher Full Text </a> | <a target=xrefwindow id=d4383e1530 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3237836">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/13357243">F1000 Recommendation</a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d4383e1543 class=n-a></a>Sibille E, Morris HM, Kota RS, <i> et al.</i>: GABA-related transcripts in the dorsolateral prefrontal cortex in mood disorders. <i>Int J Neuropsychopharmacol.</i> 2011; <b>14</b>(6): 721–34. <a target=xrefwindow id=d4383e1554 href="http://www.ncbi.nlm.nih.gov/pubmed/21226980">PubMed Abstract </a> | <a target=xrefwindow id=d4383e1557 href="https://doi.org/10.1017/S1461145710001616">Publisher Full Text </a> | <a target=xrefwindow id=d4383e1561 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3388740">Free Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d4383e1570 class=n-a></a>Rajkowska G, O'Dwyer G, Teleki Z, <i> et al.</i>: GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression. <i>Neuropsychopharmacology.</i> 2007; <b>32</b>(2): 471–82. <a target=xrefwindow id=d4383e1581 href="http://www.ncbi.nlm.nih.gov/pubmed/17063153">PubMed Abstract </a> | <a target=xrefwindow id=d4383e1584 href="https://doi.org/10.1038/sj.npp.1301234">Publisher Full Text </a> | <a target=xrefwindow id=d4383e1588 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2771699">Free Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d4383e1597 class=n-a></a>Maciag D, Hughes J, O'Dwyer G, <i> et al.</i>: Reduced density of calbindin immunoreactive GABAergic neurons in the occipital cortex in major depression: relevance to neuroimaging studies. <i>Biol Psychiatry.</i> 2010; <b>67</b>(5): 465–70. <a target=xrefwindow id=d4383e1608 href="http://www.ncbi.nlm.nih.gov/pubmed/20004363">PubMed Abstract </a> | <a target=xrefwindow id=d4383e1611 href="https://doi.org/10.1016/j.biopsych.2009.10.027">Publisher Full Text </a> | <a target=xrefwindow id=d4383e1615 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2823848">Free Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d4383e1625 class=n-a></a>Klumpers UM, Veltman DJ, Drent ML, <i> et al.</i>: Reduced parahippocampal and lateral temporal GABA<sub>A</sub>-[<sup>11</sup>C]flumazenil binding in major depression: preliminary results. <i>Eur J Nucl Med Mol Imaging.</i> 2010; <b>37</b>(3): 565–74. <a target=xrefwindow id=d4383e1643 href="http://www.ncbi.nlm.nih.gov/pubmed/19890631">PubMed Abstract </a> | <a target=xrefwindow id=d4383e1646 href="https://doi.org/10.1007/s00259-009-1292-9">Publisher Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d4383e1655 class=n-a></a>Yin H, Pantazatos SP, Galfalvy H, <i> et al.</i>: A pilot integrative genomics study of GABA and glutamate neurotransmitter systems in suicide, suicidal behavior, and major depressive disorder. <i>Am J Med Genet B Neuropsychiatr Genet.</i> 2016; <b>171B</b>(3): 414–26. <a target=xrefwindow id=d4383e1666 href="http://www.ncbi.nlm.nih.gov/pubmed/26892569">PubMed Abstract </a> | <a target=xrefwindow id=d4383e1669 href="https://doi.org/10.1002/ajmg.b.32423">Publisher Full Text </a> | <a target=xrefwindow id=d4383e1673 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4851346">Free Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d4383e1682 class=n-a></a>Poulter MO, Du L, Weaver IC, <i> et al.</i>: GABA<sub>A</sub> receptor promoter hypermethylation in suicide brain: implications for the involvement of epigenetic processes. <i>Biol Psychiatry.</i> 2008; <b>64</b>(8): 645–52. <a target=xrefwindow id=d4383e1696 href="http://www.ncbi.nlm.nih.gov/pubmed/18639864">PubMed Abstract </a> | <a target=xrefwindow id=d4383e1700 href="https://doi.org/10.1016/j.biopsych.2008.05.028">Publisher Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d4383e1709 class=n-a></a>Levinson AJ, Fitzgerald PB, Favalli G, <i> et al.</i>: Evidence of cortical inhibitory deficits in major depressive disorder. <i>Biol Psychiatry.</i> 2010; <b>67</b>(5): 458–64. <a target=xrefwindow id=d4383e1720 href="http://www.ncbi.nlm.nih.gov/pubmed/19922906">PubMed Abstract </a> | <a target=xrefwindow id=d4383e1723 href="https://doi.org/10.1016/j.biopsych.2009.09.025">Publisher Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d4383e1732 class=n-a></a>Murphy JM, Horton NJ, Laird NM, <i> et al.</i>: Anxiety and depression: a 40-year perspective on relationships regarding prevalence, distribution, and comorbidity. <i>Acta Psychiatr Scand.</i> 2004; <b>109</b>(5): 355–75. <a target=xrefwindow id=d4383e1743 href="http://www.ncbi.nlm.nih.gov/pubmed/15049772">PubMed Abstract </a> | <a target=xrefwindow id=d4383e1746 href="https://doi.org/10.1111/j.1600-0447.2003.00286.x">Publisher Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d4383e1755 class=n-a></a>Shen Q, Fuchs T, Sahir N, <i> et al.</i>: GABAergic control of critical developmental periods for anxiety- and depression-related behavior in mice. <i>PLoS One.</i> 2012; <b>7</b>(10): e47441. <a target=xrefwindow id=d4383e1766 href="http://www.ncbi.nlm.nih.gov/pubmed/23071808">PubMed Abstract </a> | <a target=xrefwindow id=d4383e1769 href="https://doi.org/10.1371/journal.pone.0047441">Publisher Full Text </a> | <a target=xrefwindow id=d4383e1773 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3469546">Free Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d4383e1783 class=n-a></a>Kendler KS, Gatz M, Gardner CO, <i> et al.</i>: A Swedish national twin study of lifetime major depression. <i>Am J Psychiatry.</i> 2006; <b>163</b>(1): 109–14. <a target=xrefwindow id=d4383e1794 href="http://www.ncbi.nlm.nih.gov/pubmed/16390897">PubMed Abstract </a> | <a target=xrefwindow id=d4383e1797 href="https://doi.org/10.1176/appi.ajp.163.1.109">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d4383e1806 class=n-a></a>Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium, Ripke S, Wray NR, <i> et al.</i>: A mega-analysis of genome-wide association studies for major depressive disorder. <i>Mol Psychiatry.</i> 2013; <b>18</b>(4): 497–511. <a target=xrefwindow id=d4383e1817 href="http://www.ncbi.nlm.nih.gov/pubmed/22472876">PubMed Abstract </a> | <a target=xrefwindow id=d4383e1820 href="https://doi.org/10.1038/mp.2012.21">Publisher Full Text </a> | <a target=xrefwindow id=d4383e1824 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3837431">Free Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/735287913"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4383e1833 class=n-a></a>Border R, Johnson EC, Evans LM, <i> et al.</i>: No Support for Historical Candidate Gene or Candidate Gene-by-Interaction Hypotheses for Major Depression Across Multiple Large Samples. <i>Am J Psychiatry.</i> 2019; <b>176</b>(5): 376–387. <a target=xrefwindow id=d4383e1844 href="http://www.ncbi.nlm.nih.gov/pubmed/30845820">PubMed Abstract </a> | <a target=xrefwindow id=d4383e1847 href="https://doi.org/10.1176/appi.ajp.2018.18070881">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/735287913">F1000 Recommendation</a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d4383e1860 class=n-a></a>Yan HC, Cao X, Das M, <i> et al.</i>: Behavioral animal models of depression. <i>Neurosci Bull.</i> 2010; <b>26</b>(4): 327–37. <a target=xrefwindow id=d4383e1871 href="http://www.ncbi.nlm.nih.gov/pubmed/20651815">PubMed Abstract </a> | <a target=xrefwindow id=d4383e1874 href="https://doi.org/10.1007/s12264-010-0323-7">Publisher Full Text </a> | <a target=xrefwindow id=d4383e1878 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5552573">Free Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725444005"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4383e1887 class=n-a></a>Czéh B, Fuchs E, Wiborg O, <i> et al.</i>: Animal models of major depression and their clinical implications. <i>Prog Neuropsychopharmacol Biol Psychiatry.</i> 2016; <b>64</b>: 293–310. <a target=xrefwindow id=d4383e1898 href="http://www.ncbi.nlm.nih.gov/pubmed/25891248">PubMed Abstract </a> | <a target=xrefwindow id=d4383e1901 href="https://doi.org/10.1016/j.pnpbp.2015.04.004">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725444005">F1000 Recommendation</a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d4383e1914 class=n-a></a>Samuels BA, Hen R: Neurogenesis and affective disorders. <i>Eur J Neurosci.</i> 2011; <b>33</b>(6): 1152–9. <a target=xrefwindow id=d4383e1922 href="http://www.ncbi.nlm.nih.gov/pubmed/21395859">PubMed Abstract </a> | <a target=xrefwindow id=d4383e1925 href="https://doi.org/10.1111/j.1460-9568.2011.07614.x">Publisher Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d4383e1935 class=n-a></a>Czéh B, Varga ZK, Henningsen K, <i> et al.</i>: Chronic stress reduces the number of GABAergic interneurons in the adult rat hippocampus, dorsal-ventral and region-specific differences. <i>Hippocampus.</i> 2015; <b>25</b>(3): 393–405. <a target=xrefwindow id=d4383e1946 href="http://www.ncbi.nlm.nih.gov/pubmed/25331166">PubMed Abstract </a> | <a target=xrefwindow id=d4383e1949 href="https://doi.org/10.1002/hipo.22382">Publisher Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726669630"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4383e1958 class=n-a></a>Varga Z, Csabai D, Miseta A, <i> et al.</i>: Chronic stress affects the number of GABAergic neurons in the orbitofrontal cortex of rats. <i>Behav Brain Res.</i> 2017; <b>316</b>: 104–14. <a target=xrefwindow id=d4383e1969 href="http://www.ncbi.nlm.nih.gov/pubmed/27555539">PubMed Abstract </a> | <a target=xrefwindow id=d4383e1972 href="https://doi.org/10.1016/j.bbr.2016.08.030">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726669630">F1000 Recommendation</a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d4383e1985 class=n-a></a>Lin LC, Sibille E: Somatostatin, neuronal vulnerability and behavioral emotionality. <i>Mol Psychiatry.</i> 2015; <b>20</b>(3): 377–87. <a target=xrefwindow id=d4383e1993 href="http://www.ncbi.nlm.nih.gov/pubmed/25600109">PubMed Abstract </a> | <a target=xrefwindow id=d4383e1996 href="https://doi.org/10.1038/mp.2014.184">Publisher Full Text </a> | <a target=xrefwindow id=d4383e1999 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4355106">Free Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726820572"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4383e2008 class=n-a></a>Ma K, Xu A, Cui S, <i> et al.</i>: Impaired GABA synthesis, uptake and release are associated with depression-like behaviors induced by chronic mild stress. <i>Transl Psychiatry.</i> 2016; <b>6</b>(10): e910. <a target=xrefwindow id=d4383e2019 href="http://www.ncbi.nlm.nih.gov/pubmed/27701406">PubMed Abstract </a> | <a target=xrefwindow id=d4383e2022 href="https://doi.org/10.1038/tp.2016.181">Publisher Full Text </a> | <a target=xrefwindow id=d4383e2026 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5315548">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726820572">F1000 Recommendation</a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d4383e2039 class=n-a></a>Banasr M, Lepack A, Fee C, <i> et al.</i>: Characterization of GABAergic marker expression in the chronic unpredictable stress model of depression. <i>Chronic Stress (Thousand Oaks).</i> 2017; <b>1</b>. <a target=xrefwindow id=d4383e2050 href="http://www.ncbi.nlm.nih.gov/pubmed/28835932">PubMed Abstract </a> | <a target=xrefwindow id=d4383e2053 href="https://doi.org/10.1177/2470547017720459">Publisher Full Text </a> | <a target=xrefwindow id=d4383e2057 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5565173">Free Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/13940971"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4383e2066 class=n-a></a>Hewitt SA, Wamsteeker JI, Kurz EU, <i> et al.</i>: Altered chloride homeostasis removes synaptic inhibitory constraint of the stress axis. <i>Nat Neurosci.</i> 2009; <b>12</b>(4): 438–43. <a target=xrefwindow id=d4383e2077 href="http://www.ncbi.nlm.nih.gov/pubmed/19252497">PubMed Abstract </a> | <a target=xrefwindow id=d4383e2080 href="https://doi.org/10.1038/nn.2274">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/13940971">F1000 Recommendation</a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d4383e2094 class=n-a></a>MacKenzie G, Maguire J: Chronic stress shifts the GABA reversal potential in the hippocampus and increases seizure susceptibility. <i>Epilepsy Res.</i> 2015; <b>109</b>: 13–27. <a target=xrefwindow id=d4383e2102 href="http://www.ncbi.nlm.nih.gov/pubmed/25524838">PubMed Abstract </a> | <a target=xrefwindow id=d4383e2105 href="https://doi.org/10.1016/j.eplepsyres.2014.10.003">Publisher Full Text </a> | <a target=xrefwindow id=d4383e2108 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4272449">Free Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d4383e2117 class=n-a></a>Crestani F, Lorez M, Baer K, <i> et al.</i>: Decreased GABA<sub>A</sub>-receptor clustering results in enhanced anxiety and a bias for threat cues. <i>Nat Neurosci.</i> 1999; <b>2</b>(9): 833–9. <a target=xrefwindow id=d4383e2131 href="http://www.ncbi.nlm.nih.gov/pubmed/10461223%09">PubMed Abstract </a> | <a target=xrefwindow id=d4383e2135 href="https://doi.org/10.1038/12207">Publisher Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d4383e2144 class=n-a></a>Earnheart JC, Schweizer C, Crestani F, <i> et al.</i>: GABAergic control of adult hippocampal neurogenesis in relation to behavior indicative of trait anxiety and depression states. <i>J Neurosci.</i> 2007; <b>27</b>(14): 3845–54. <a target=xrefwindow id=d4383e2155 href="http://www.ncbi.nlm.nih.gov/pubmed/17409249">PubMed Abstract </a> | <a target=xrefwindow id=d4383e2158 href="https://doi.org/10.1523/JNEUROSCI.3609-06.2007">Publisher Full Text </a> | <a target=xrefwindow id=d4383e2162 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2441879">Free Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d4383e2171 class=n-a></a>Ren Z, Sahir N, Murakami S, <i> et al.</i>: Defects in dendrite and spine maturation and synaptogenesis associated with an anxious-depressive-like phenotype of GABA<sub>A</sub> receptor-deficient mice. <i>Neuropharmacology.</i> 2015; <b>88</b>: 171–9. <a target=xrefwindow id=d4383e2185 href="http://www.ncbi.nlm.nih.gov/pubmed/25107590">PubMed Abstract </a> | <a target=xrefwindow id=d4383e2189 href="https://doi.org/10.1016/j.neuropharm.2014.07.019">Publisher Full Text </a> | <a target=xrefwindow id=d4383e2192 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4252742">Free Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d4383e2201 class=n-a></a>Shen Q, Lal R, Luellen BA, <i> et al.</i>: gamma-Aminobutyric acid-type A receptor deficits cause hypothalamic-pituitary-adrenal axis hyperactivity and antidepressant drug sensitivity reminiscent of melancholic forms of depression. <i>Biol Psychiatry.</i> 2010; <b>68</b>(6): 512–20. <a target=xrefwindow id=d4383e2212 href="http://www.ncbi.nlm.nih.gov/pubmed/20579975">PubMed Abstract </a> | <a target=xrefwindow id=d4383e2215 href="https://doi.org/10.1016/j.biopsych.2010.04.024">Publisher Full Text </a> | <a target=xrefwindow id=d4383e2219 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2930197">Free Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d4383e2228 class=n-a></a>Vollenweider I, Smith KS, Keist R, <i> et al.</i>: Antidepressant-like properties of α2-containing GABA<sub>A</sub> receptors. <i>Behav Brain Res.</i> 2011; <b>217</b>(1): 77–80. <a target=xrefwindow id=d4383e2242 href="http://www.ncbi.nlm.nih.gov/pubmed/20965216">PubMed Abstract </a> | <a target=xrefwindow id=d4383e2246 href="https://doi.org/10.1016/j.bbr.2010.10.009">Publisher Full Text </a> | <a target=xrefwindow id=d4383e2249 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3023881">Free Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d4383e2259 class=n-a></a>Durkin EJ, Muessig L, Herlt T, <i> et al.</i>: Brain neurosteroids are natural anxiolytics targeting α2 subunit γ-aminobutyric acid type-A receptors. <i>BioRxiv.</i> Preprint first posted online Nov. 8, 2018, 2018. <a target=xrefwindow id=d4383e2267 href="https://doi.org/10.1101/462457">Publisher Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732542104"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4383e2276 class=n-a></a>Kolata SM, Nakao K, Jeevakumar V, <i> et al.</i>: Neuropsychiatric Phenotypes Produced by GABA Reduction in Mouse Cortex and Hippocampus. <i>Neuropsychopharmacology.</i> 2018; <b>43</b>(6): 1445–56. <a target=xrefwindow id=d4383e2287 href="http://www.ncbi.nlm.nih.gov/pubmed/29362511">PubMed Abstract </a> | <a target=xrefwindow id=d4383e2290 href="https://doi.org/10.1038/npp.2017.296">Publisher Full Text </a> | <a target=xrefwindow id=d4383e2294 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5916365">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732542104">F1000 Recommendation</a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725445074"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4383e2307 class=n-a></a>Fischell J, van Dyke AM, Kvarta MD, <i> et al.</i>: Rapid Antidepressant Action and Restoration of Excitatory Synaptic Strength After Chronic Stress by Negative Modulators of Alpha5-Containing GABAA Receptors. <i>Neuropsychopharmacology.</i> 2015; <b>40</b>(11): 2499–509. <a target=xrefwindow id=d4383e2318 href="http://www.ncbi.nlm.nih.gov/pubmed/25900119">PubMed Abstract </a> | <a target=xrefwindow id=d4383e2321 href="https://doi.org/10.1038/npp.2015.112">Publisher Full Text </a> | <a target=xrefwindow id=d4383e2325 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4569955">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725445074">F1000 Recommendation</a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d4383e2338 class=n-a></a>Yuen EY, Wei J, Liu W, <i> et al.</i>: Repeated stress causes cognitive impairment by suppressing glutamate receptor expression and function in prefrontal cortex. <i>Neuron.</i> 2012; <b>73</b>(5): 962–77. <a target=xrefwindow id=d4383e2349 href="http://www.ncbi.nlm.nih.gov/pubmed/22405206">PubMed Abstract </a> | <a target=xrefwindow id=d4383e2352 href="https://doi.org/10.1016/j.neuron.2011.12.033">Publisher Full Text </a> | <a target=xrefwindow id=d4383e2356 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3302010">Free Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d4383e2365 class=n-a></a>Ren Z, Pribiag H, Jefferson SJ, <i> et al.</i>: Bidirectional Homeostatic Regulation of a Depression-Related Brain State by Gamma-Aminobutyric Acidergic Deficits and Ketamine Treatment. <i>Biol Psychiatry.</i> 2016; <b>80</b>(6): 457–68. <a target=xrefwindow id=d4383e2376 href="http://www.ncbi.nlm.nih.gov/pubmed/27062563">PubMed Abstract </a> | <a target=xrefwindow id=d4383e2379 href="https://doi.org/10.1016/j.biopsych.2016.02.009">Publisher Full Text </a> | <a target=xrefwindow id=d4383e2383 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4983262">Free Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726794915"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4383e2392 class=n-a></a>Anderson RJ, Hoy KE, Daskalakis ZJ, <i> et al.</i>: Repetitive transcranial magnetic stimulation for treatment resistant depression: Re-establishing connections. <i>Clin Neurophysiol.</i> 2016; <b>127</b>(11): 3394–405. <a target=xrefwindow id=d4383e2403 href="http://www.ncbi.nlm.nih.gov/pubmed/27672727">PubMed Abstract </a> | <a target=xrefwindow id=d4383e2406 href="https://doi.org/10.1016/j.clinph.2016.08.015">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726794915">F1000 Recommendation</a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/730351907"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4383e2420 class=n-a></a>Abdallah CG, Averill CL, Salas R, <i> et al.</i>: Prefrontal Connectivity and Glutamate Transmission: Relevance to Depression Pathophysiology and Ketamine Treatment. <i>Biol Psychiatry Cogn Neurosci Neuroimaging.</i> 2017; <b>2</b>(7): 566–74. <a target=xrefwindow id=d4383e2431 href="http://www.ncbi.nlm.nih.gov/pubmed/29034354">PubMed Abstract </a> | <a target=xrefwindow id=d4383e2434 href="https://doi.org/10.1016/j.bpsc.2017.04.006">Publisher Full Text </a> | <a target=xrefwindow id=d4383e2438 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5635826">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/730351907">F1000 Recommendation</a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734009213"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4383e2451 class=n-a></a>Zhang H, Chaudhury D, Nectow AR, <i> et al.</i>: α<sub>1</sub>- and β<sub>3</sub>-Adrenergic Receptor-Mediated Mesolimbic Homeostatic Plasticity Confers Resilience to Social Stress in Susceptible Mice. <i>Biol Psychiatry.</i> 2019; <b>85</b>(3): 226–36. <a target=xrefwindow id=d4383e2469 href="http://www.ncbi.nlm.nih.gov/pubmed/30336931">PubMed Abstract </a> | <a target=xrefwindow id=d4383e2472 href="https://doi.org/10.1016/j.biopsych.2018.08.020">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734009213">F1000 Recommendation</a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726943368"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4383e2485 class=n-a></a>Fuchs T, Jefferson SJ, Hooper A, <i> et al.</i>: Disinhibition of somatostatin-positive GABAergic interneurons results in an anxiolytic and antidepressant-like brain state. <i>Mol Psychiatry.</i> 2017; <b>22</b>(6): 920–30. <a target=xrefwindow id=d4383e2496 href="http://www.ncbi.nlm.nih.gov/pubmed/27821870">PubMed Abstract </a> | <a target=xrefwindow id=d4383e2499 href="https://doi.org/10.1038/mp.2016.188">Publisher Full Text </a> | <a target=xrefwindow id=d4383e2503 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5422144">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726943368">F1000 Recommendation</a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d4383e2516 class=n-a></a>Benasi G, Guidi J, Offidani E, <i> et al.</i>: Benzodiazepines as a Monotherapy in Depressive Disorders: A Systematic Review. <i>Psychother Psychosom.</i> 2018; <b>87</b>(2): 65–74. <a target=xrefwindow id=d4383e2527 href="http://www.ncbi.nlm.nih.gov/pubmed/29466801">PubMed Abstract </a> | <a target=xrefwindow id=d4383e2530 href="https://doi.org/10.1159/000486696">Publisher Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d4383e2539 class=n-a></a>Petty F, Trivedi MH, Fulton M, <i> et al.</i>: Benzodiazepines as antidepressants: does GABA play a role in depression? <i>Biol Psychiatry.</i> 1995; <b>38</b>(9): 578–91. <a target=xrefwindow id=d4383e2550 href="http://www.ncbi.nlm.nih.gov/pubmed/8573660">PubMed Abstract </a> | <a target=xrefwindow id=d4383e2553 href="https://doi.org/10.1016/0006-3223(95)00049-7">Publisher Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d4383e2562 class=n-a></a>Birkenhäger TK, Moleman P, Nolen WA: Benzodiazepines for depression? A review of the literature. <i>Int Clin Psychopharmacol.</i> 1995; <b>10</b>(3): 181–95. <a target=xrefwindow id=d4383e2570 href="http://www.ncbi.nlm.nih.gov/pubmed/8675972">PubMed Abstract </a> | <a target=xrefwindow id=d4383e2573 href="https://doi.org/10.1097/00004850-199510030-00008">Publisher Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d4383e2583 class=n-a></a>Furukawa TA, Streiner DL, Young LT: Antidepressant and benzodiazepine for major depression. <i>Cochrane Database Syst Rev.</i> 2002; (1): CD001026. <a target=xrefwindow id=d4383e2588 href="http://www.ncbi.nlm.nih.gov/pubmed/11869584">PubMed Abstract </a> | <a target=xrefwindow id=d4383e2591 href="https://doi.org/10.1002/14651858.CD001026">Publisher Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d4383e2600 class=n-a></a>Delamarre L, Galvao F, Gohier B, <i> et al.</i>: How Much Do Benzodiazepines Matter for Electroconvulsive Therapy in Patients With Major Depression? <i>J ECT.</i> 2019. <a target=xrefwindow id=d4383e2608 href="http://www.ncbi.nlm.nih.gov/pubmed/30720551">PubMed Abstract </a> | <a target=xrefwindow id=d4383e2611 href="https://doi.org/10.1097/YCT.0000000000000574">Publisher Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d4383e2620 class=n-a></a>Jacob TC, Michels G, Silayeva L, <i> et al.</i>: Benzodiazepine treatment induces subtype-specific changes in GABA<sub>A</sub> receptor trafficking and decreases synaptic inhibition. <i>Proc Natl Acad Sci U S A.</i> 2012; <b>109</b>(45): 18595–600. <a target=xrefwindow id=d4383e2634 href="http://www.ncbi.nlm.nih.gov/pubmed/23091016">PubMed Abstract </a> | <a target=xrefwindow id=d4383e2638 href="https://doi.org/10.1073/pnas.1204994109">Publisher Full Text </a> | <a target=xrefwindow id=d4383e2641 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3494928">Free Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733455059"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4383e2650 class=n-a></a>Nicholson MW, Sweeney A, Pekle E, <i> et al.</i>: Diazepam-induced loss of inhibitory synapses mediated by PLCδ/ Ca<sup>2+</sup>/calcineurin signalling downstream of GABAA receptors. <i>Mol Psychiatry.</i> 2018; <b>23</b>(9): 1851–67. <a target=xrefwindow id=d4383e2664 href="http://www.ncbi.nlm.nih.gov/pubmed/29904150">PubMed Abstract </a> | <a target=xrefwindow id=d4383e2668 href="https://doi.org/10.1038/s41380-018-0100-y">Publisher Full Text </a> | <a target=xrefwindow id=d4383e2671 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6232101">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733455059">F1000 Recommendation</a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727390292"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4383e2684 class=n-a></a>Zanos P, Nelson ME, Highland JN, <i> et al.</i>: A Negative Allosteric Modulator for α5 Subunit-Containing GABA Receptors Exerts a Rapid and Persistent Antidepressant-Like Action without the Side Effects of the NMDA Receptor Antagonist Ketamine in Mice. <i>eNeuro.</i> 2017; <b>4</b>(1): pii: ENEURO.0285-16.2017. <a target=xrefwindow id=d4383e2695 href="http://www.ncbi.nlm.nih.gov/pubmed/28275719">PubMed Abstract </a> | <a target=xrefwindow id=d4383e2698 href="https://doi.org/10.1523/ENEURO.0285-16.2017">Publisher Full Text </a> | <a target=xrefwindow id=d4383e2702 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5334634">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727390292">F1000 Recommendation</a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/735371319"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4383e2715 class=n-a></a>Duman RS, Shinohara R, Fogaça MV, <i> et al.</i>: Neurobiology of rapid-acting antidepressants: convergent effects on GluA1-synaptic function. <i>Mol Psychiatry.</i> 2019. <a target=xrefwindow id=d4383e2723 href="http://www.ncbi.nlm.nih.gov/pubmed/30894661">PubMed Abstract </a> | <a target=xrefwindow id=d4383e2726 href="https://doi.org/10.1038/s41380-019-0400-x">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/735371319">F1000 Recommendation</a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d4383e2740 class=n-a></a>Zanos P, Thompson SM, Duman RS, <i> et al.</i>: Convergent Mechanisms Underlying Rapid Antidepressant Action. <i>CNS Drugs.</i> 2018; <b>32</b>(3): 197–227. <a target=xrefwindow id=d4383e2751 href="http://www.ncbi.nlm.nih.gov/pubmed/29516301">PubMed Abstract </a> | <a target=xrefwindow id=d4383e2754 href="https://doi.org/10.1007/s40263-018-0492-x">Publisher Full Text </a> | <a target=xrefwindow id=d4383e2758 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6005380">Free Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732838229"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4383e2767 class=n-a></a>Widman AJ, McMahon LL: Disinhibition of CA1 pyramidal cells by low-dose ketamine and other antagonists with rapid antidepressant efficacy. <i>Proc Natl Acad Sci U S A.</i> 2018; <b>115</b>(13): E3007–E3016. <a target=xrefwindow id=d4383e2775 href="http://www.ncbi.nlm.nih.gov/pubmed/29531088">PubMed Abstract </a> | <a target=xrefwindow id=d4383e2778 href="https://doi.org/10.1073/pnas.1718883115">Publisher Full Text </a> | <a target=xrefwindow id=d4383e2781 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5879689">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732838229">F1000 Recommendation</a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726282290"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4383e2794 class=n-a></a>Chowdhury GM, Zhang J, Thomas M, <i> et al.</i>: Transiently increased glutamate cycling in rat PFC is associated with rapid onset of antidepressant-like effects. <i>Mol Psychiatry.</i> 2017; <b>22</b>(1): 120–6. <a target=xrefwindow id=d4383e2805 href="http://www.ncbi.nlm.nih.gov/pubmed/27067013">PubMed Abstract </a> | <a target=xrefwindow id=d4383e2808 href="https://doi.org/10.1038/mp.2016.34">Publisher Full Text </a> | <a target=xrefwindow id=d4383e2812 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5345902">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726282290">F1000 Recommendation</a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/11807956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4383e2825 class=n-a></a>Autry AE, Adachi M, Nosyreva E, <i> et al.</i>: NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. <i>Nature.</i> 2011; <b>475</b>(7354): 91–5. <a target=xrefwindow id=d4383e2836 href="http://www.ncbi.nlm.nih.gov/pubmed/21677641">PubMed Abstract </a> | <a target=xrefwindow id=d4383e2839 href="https://doi.org/10.1038/nature10130">Publisher Full Text </a> | <a target=xrefwindow id=d4383e2843 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3172695">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/11807956">F1000 Recommendation</a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/5372956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4383e2856 class=n-a></a>Li N, Lee B, Liu RJ, <i> et al.</i>: mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. <i>Science.</i> 2010; <b>329</b>(5994): 959–64. <a target=xrefwindow id=d4383e2867 href="http://www.ncbi.nlm.nih.gov/pubmed/20724638">PubMed Abstract </a> | <a target=xrefwindow id=d4383e2870 href="https://doi.org/10.1126/science.1190287">Publisher Full Text </a> | <a target=xrefwindow id=d4383e2874 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3116441">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/5372956">F1000 Recommendation</a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/8778956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4383e2887 class=n-a></a>Li N, Liu RJ, Dwyer JM, <i> et al.</i>: Glutamate <i>N</i>-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure. <i>Biol Psychiatry.</i> 2011; <b>69</b>(8): 754–61. <a target=xrefwindow id=d4383e2901 href="http://www.ncbi.nlm.nih.gov/pubmed/21292242">PubMed Abstract </a> | <a target=xrefwindow id=d4383e2905 href="https://doi.org/10.1016/j.biopsych.2010.12.015">Publisher Full Text </a> | <a target=xrefwindow id=d4383e2908 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3068225">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/8778956">F1000 Recommendation</a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/735548524"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4383e2922 class=n-a></a>Fitzgerald PJ, Yen JY, Watson BO: Stress-sensitive antidepressant-like effects of ketamine in the mouse forced swim test. <i>PLoS One.</i> 2019; <b>14</b>(4): e0215554. <a target=xrefwindow id=d4383e2930 href="http://www.ncbi.nlm.nih.gov/pubmed/30986274">PubMed Abstract </a> | <a target=xrefwindow id=d4383e2933 href="https://doi.org/10.1371/journal.pone.0215554">Publisher Full Text </a> | <a target=xrefwindow id=d4383e2936 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6464213">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/735548524">F1000 Recommendation</a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d4383e2949 class=n-a></a>Hesdorffer DC, Hauser WA, Annegers JF, <i> et al.</i>: Major depression is a risk factor for seizures in older adults. <i>Ann Neurol.</i> 2000; <b>47</b>(2): 246–9. <a target=xrefwindow id=d4383e2960 href="http://www.ncbi.nlm.nih.gov/pubmed/10665498">PubMed Abstract </a> | <a target="xrefwindow" id="d4383e2963" href="https://doi.org/ 10.1002/1531-8249(200002)47:2<246::AID-ANA17&gt;3.0.CO;2-E">Publisher Full Text </a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a name=d4383e2972 class=n-a></a>Belelli D, Lambert JJ: Neurosteroids: endogenous regulators of the GABA<sub>A</sub> receptor. <i>Nat Rev Neurosci.</i> 2005; <b>6</b>(7): 565–75. <a target=xrefwindow id=d4383e2983 href="http://www.ncbi.nlm.nih.gov/pubmed/15959466">PubMed Abstract </a> | <a target=xrefwindow id=d4383e2986 href="https://doi.org/10.1038/nrn1703">Publisher Full Text </a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d4383e2995 class=n-a></a>Majewska MD, Harrison NL, Schwartz RD, <i> et al.</i>: Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. <i>Science.</i> 1986; <b>232</b>(4753): 1004–7. <a target=xrefwindow id=d4383e3006 href="http://www.ncbi.nlm.nih.gov/pubmed/2422758">PubMed Abstract </a> | <a target=xrefwindow id=d4383e3009 href="https://doi.org/10.1126/science.2422758">Publisher Full Text </a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d4383e3018 class=n-a></a>Paul SM, Purdy RH: Neuroactive steroids. <i>FASEB J.</i> 1992; <b>6</b>(6): 2311–22. <a target=xrefwindow id=d4383e3026 href="http://www.ncbi.nlm.nih.gov/pubmed/1347506">PubMed Abstract </a> | <a target=xrefwindow id=d4383e3029 href="https://doi.org/10.1096/fasebj.6.6.1347506">Publisher Full Text </a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726852378"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4383e3038 class=n-a></a>Modgil A, Parakala ML, Ackley MA, <i> et al.</i>: Endogenous and synthetic neuroactive steroids evoke sustained increases in the efficacy of GABAergic inhibition via a protein kinase C-dependent mechanism. <i>Neuropharmacology.</i> 2017; <b>113</b>(Pt A): 314–22. <a target=xrefwindow id=d4383e3049 href="http://www.ncbi.nlm.nih.gov/pubmed/27743930">PubMed Abstract </a> | <a target=xrefwindow id=d4383e3052 href="https://doi.org/10.1016/j.neuropharm.2016.10.010">Publisher Full Text </a> | <a target=xrefwindow id=d4383e3056 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5148695">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726852378">F1000 Recommendation</a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734202313"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4383e3070 class=n-a></a>Sieghart W, Savić MM: International Union of Basic and Clinical Pharmacology. CVI: GABA<sub>A</sub> Receptor Subtype- and Function-selective Ligands: Key Issues in Translation to Humans. <i>Pharmacol Rev.</i> 2018; <b>70</b>(4): 836–78. <a target=xrefwindow id=d4383e3081 href="http://www.ncbi.nlm.nih.gov/pubmed/30275042">PubMed Abstract </a> | <a target=xrefwindow id=d4383e3084 href="https://doi.org/10.1124/pr.117.014449">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734202313">F1000 Recommendation</a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d4383e3097 class=n-a></a>Fritschy JM, Panzanelli P: GABA<sub>A</sub> receptors and plasticity of inhibitory neurotransmission in the central nervous system. <i>Eur J Neurosci.</i> 2014; <b>39</b>(11): 1845–65. <a target=xrefwindow id=d4383e3108 href="http://www.ncbi.nlm.nih.gov/pubmed/24628861">PubMed Abstract </a> | <a target=xrefwindow id=d4383e3111 href="https://doi.org/10.1111/ejn.12534">Publisher Full Text </a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a name=d4383e3120 class=n-a></a>Rudolph U, Knoflach F: Beyond classical benzodiazepines: novel therapeutic potential of GABA<sub>A</sub> receptor subtypes. <i>Nat Rev Drug Discov.</i> 2011; <b>10</b>(9): 685–97. <a target=xrefwindow id=d4383e3131 href="http://www.ncbi.nlm.nih.gov/pubmed/21799515">PubMed Abstract </a> | <a target=xrefwindow id=d4383e3134 href="https://doi.org/10.1038/nrd3502">Publisher Full Text </a> | <a target=xrefwindow id=d4383e3138 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3375401">Free Full Text </a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a name=d4383e3147 class=n-a></a>Adams JM, Thomas P, Smart TG: Modulation of neurosteroid potentiation by protein kinases at synaptic- and extrasynaptic-type GABA<sub>A</sub> receptors. <i>Neuropharmacology.</i> 2015; <b>88</b>: 63–73. <a target=xrefwindow id=d4383e3158 href="http://www.ncbi.nlm.nih.gov/pubmed/25278033">PubMed Abstract </a> | <a target=xrefwindow id=d4383e3161 href="https://doi.org/10.1016/j.neuropharm.2014.09.021">Publisher Full Text </a> | <a target=xrefwindow id=d4383e3165 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4239298">Free Full Text </a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a name=d4383e3174 class=n-a></a>Herd MB, Brown AR, Lambert JJ, <i> et al.</i>: Extrasynaptic GABA<sub>A</sub> receptors couple presynaptic activity to postsynaptic inhibition in the somatosensory thalamus. <i>J Neurosci.</i> 2013; <b>33</b>(37): 14850–68. <a target=xrefwindow id=d4383e3188 href="http://www.ncbi.nlm.nih.gov/pubmed/24027285">PubMed Abstract </a> | <a target=xrefwindow id=d4383e3192 href="https://doi.org/10.1523/JNEUROSCI.1174-13.2013">Publisher Full Text </a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a name=d4383e3201 class=n-a></a>Uzunova V, Sheline Y, Davis JM, <i> et al.</i>: Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. <i>Proc Natl Acad Sci U S A.</i> 1998; <b>95</b>(6): 3239–44. <a target=xrefwindow id=d4383e3212 href="http://www.ncbi.nlm.nih.gov/pubmed/9501247">PubMed Abstract </a> | <a target=xrefwindow id=d4383e3215 href="https://doi.org/10.1073/pnas.95.6.3239">Publisher Full Text </a> | <a target=xrefwindow id=d4383e3219 href="http://www.ncbi.nlm.nih.gov/pmc/articles/19726">Free Full Text </a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734870634"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4383e3229 class=n-a></a>Murugan S, Jakka P, Namani S, <i> et al.</i>: The neurosteroid pregnenolone promotes degradation of key proteins in the innate immune signaling to suppress inflammation. <i>J Biol Chem.</i> 2019; <b>294</b>(12): 4596–607. <a target=xrefwindow id=d4383e3240 href="http://www.ncbi.nlm.nih.gov/pubmed/30647133">PubMed Abstract </a> | <a target=xrefwindow id=d4383e3243 href="https://doi.org/10.1074/jbc.RA118.005543">Publisher Full Text </a> | <a target=xrefwindow id=d4383e3247 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6433066">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734870634">F1000 Recommendation</a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a name=d4383e3260 class=n-a></a>Schüle C, Romeo E, Uzunov DP, <i> et al.</i>: Influence of mirtazapine on plasma concentrations of neuroactive steroids in major depression and on 3alpha-hydroxysteroid dehydrogenase activity. <i>Mol Psychiatry.</i> 2006; <b>11</b>(3): 261–72. <a target=xrefwindow id=d4383e3271 href="http://www.ncbi.nlm.nih.gov/pubmed/16344854">PubMed Abstract </a> | <a target=xrefwindow id=d4383e3274 href="https://doi.org/10.1038/sj.mp.4001782">Publisher Full Text </a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a name=d4383e3283 class=n-a></a>Nappi RE, Petraglia F, Luisi S, <i> et al.</i>: Serum allopregnanolone in women with postpartum "blues". <i>Obstet Gynecol.</i> 2001; <b>97</b>(1): 77–80. <a target=xrefwindow id=d4383e3294 href="http://www.ncbi.nlm.nih.gov/pubmed/11152912">PubMed Abstract </a> | <a target=xrefwindow id=d4383e3297 href="https://doi.org/10.1016/S0029-7844(00)01112-1">Publisher Full Text </a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a name=d4383e3306 class=n-a></a>Rasmusson AM, Pinna G, Paliwal P, <i> et al.</i>: Decreased cerebrospinal fluid allopregnanolone levels in women with posttraumatic stress disorder. <i>Biol Psychiatry.</i> 2006; <b>60</b>(7): 704–13. <a target=xrefwindow id=d4383e3317 href="http://www.ncbi.nlm.nih.gov/pubmed/16934764">PubMed Abstract </a> | <a target=xrefwindow id=d4383e3320 href="https://doi.org/10.1016/j.biopsych.2006.03.026">Publisher Full Text </a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734616226"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4383e3329 class=n-a></a>Rasmusson AM, King MW, Valovski I, <i> et al.</i>: Relationships between cerebrospinal fluid GABAergic neurosteroid levels and symptom severity in men with PTSD. <i>Psychoneuroendocrinology.</i> 2019; <b>102</b>: 95–104. <a target=xrefwindow id=d4383e3340 href="http://www.ncbi.nlm.nih.gov/pubmed/30529908">PubMed Abstract </a> | <a target=xrefwindow id=d4383e3343 href="https://doi.org/10.1016/j.psyneuen.2018.11.027">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734616226">F1000 Recommendation</a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1165178"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4383e3356 class=n-a></a>Marx CE, Keefe RS, Buchanan RW, <i> et al.</i>: Proof-of-concept trial with the neurosteroid pregnenolone targeting cognitive and negative symptoms in schizophrenia. <i>Neuropsychopharmacology.</i> 2009; <b>34</b>(8): 1885–903. <a target=xrefwindow id=d4383e3367 href="http://www.ncbi.nlm.nih.gov/pubmed/19339966">PubMed Abstract </a> | <a target=xrefwindow id=d4383e3370 href="https://doi.org/10.1038/npp.2009.26">Publisher Full Text </a> | <a target=xrefwindow id=d4383e3374 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3427920">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1165178">F1000 Recommendation</a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725638930"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4383e3388 class=n-a></a>Naylor JC, Kilts JD, Szabo ST, <i> et al.</i>: Allopregnanolone Levels Are Inversely Associated with Self-Reported Pain Symptoms in U.S. Iraq and Afghanistan-Era Veterans: Implications for Biomarkers and Therapeutics. <i>Pain Med.</i> 2016; <b>17</b>(1): 25–32. <a target=xrefwindow id=d4383e3399 href="http://www.ncbi.nlm.nih.gov/pubmed/26176345">PubMed Abstract </a> | <a target=xrefwindow id=d4383e3402 href="https://doi.org/10.1111/pme.12860">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725638930">F1000 Recommendation</a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a name=d4383e3415 class=n-a></a>Ströhle A, Romeo E, di Michele F, <i> et al.</i>: Induced panic attacks shift gamma-aminobutyric acid type A receptor modulatory neuroactive steroid composition in patients with panic disorder: preliminary results. <i>Arch Gen Psychiatry.</i> 2003; <b>60</b>(2): 161–8. <a target=xrefwindow id=d4383e3426 href="http://www.ncbi.nlm.nih.gov/pubmed/12578433">PubMed Abstract </a> | <a target=xrefwindow id=d4383e3429 href="https://doi.org/10.1001/archpsyc.60.2.161">Publisher Full Text </a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a name=d4383e3438 class=n-a></a>Le Mellédo JM, Baker GB: Neuroactive steroids and anxiety disorders. <i>J Psychiatry Neurosci.</i> 2002; <b>27</b>(3): 161–5. <a target=xrefwindow id=d4383e3446 href="http://www.ncbi.nlm.nih.gov/pubmed/12066445">PubMed Abstract </a> | <a target=xrefwindow id=d4383e3449 href="http://www.ncbi.nlm.nih.gov/pmc/articles/161645">Free Full Text </a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a name=d4383e3458 class=n-a></a>Prince RJ, Simmonds MA: 5 beta-pregnan-3 beta-ol-20-one, a specific antagonist at the neurosteroid site of the GABAA receptor-complex. <i>Neurosci Lett.</i> 1992; <b>135</b>(2): 273–5. <a target=xrefwindow id=d4383e3466 href="http://www.ncbi.nlm.nih.gov/pubmed/1320747">PubMed Abstract </a> | <a target=xrefwindow id=d4383e3469 href="https://doi.org/10.1016/0304-3940(92)90454-F">Publisher Full Text </a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a name=d4383e3478 class=n-a></a>Luchetti S, Huitinga I, Swaab DF: Neurosteroid and GABA-A receptor alterations in Alzheimer's disease, Parkinson's disease and multiple sclerosis. <i>Neuroscience.</i> 2011; <b>191</b>: 6–21. <a target=xrefwindow id=d4383e3486 href="http://www.ncbi.nlm.nih.gov/pubmed/21514366">PubMed Abstract </a> | <a target=xrefwindow id=d4383e3489 href="https://doi.org/10.1016/j.neuroscience.2011.04.010">Publisher Full Text </a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a name=d4383e3498 class=n-a></a>Girdler SS, Klatzkin R: Neurosteroids in the context of stress: implications for depressive disorders. <i>Pharmacol Ther.</i> 2007; <b>116</b>(1): 125–39. <a target=xrefwindow id=d4383e3506 href="http://www.ncbi.nlm.nih.gov/pubmed/17597217">PubMed Abstract </a> | <a target=xrefwindow id=d4383e3509 href="https://doi.org/10.1016/j.pharmthera.2007.05.006">Publisher Full Text </a> | <a target=xrefwindow id=d4383e3512 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2650267">Free Full Text </a></span></li><li><a name=ref-90 class=n-a></a><span class=label>90. </span>&nbsp;<span class=citation><a name=d4383e3522 class=n-a></a>Purdy RH, Morrow AL, Moore PH Jr, <i> et al.</i>: Stress-induced elevations of gamma-aminobutyric acid type A receptor-active steroids in the rat brain. <i>Proc Natl Acad Sci U S A.</i> 1991; <b>88</b>(10): 4553–7. <a target=xrefwindow id=d4383e3533 href="http://www.ncbi.nlm.nih.gov/pubmed/1852011">PubMed Abstract </a> | <a target=xrefwindow id=d4383e3536 href="https://doi.org/10.1073/pnas.88.10.4553">Publisher Full Text </a> | <a target=xrefwindow id=d4383e3540 href="http://www.ncbi.nlm.nih.gov/pmc/articles/51699">Free Full Text </a></span></li><li><a name=ref-91 class=n-a></a><span class=label>91. </span>&nbsp;<span class=citation><a name=d4383e3549 class=n-a></a>Dong E, Matsumoto K, Uzunova V, <i> et al.</i>: Brain 5alpha-dihydroprogesterone and allopregnanolone synthesis in a mouse model of protracted social isolation. <i>Proc Natl Acad Sci U S A.</i> 2001; <b>98</b>(5): 2849–54. <a target=xrefwindow id=d4383e3560 href="http://www.ncbi.nlm.nih.gov/pubmed/11226329">PubMed Abstract </a> | <a target=xrefwindow id=d4383e3563 href="https://doi.org/10.1073/pnas.051628598">Publisher Full Text </a> | <a target=xrefwindow id=d4383e3567 href="http://www.ncbi.nlm.nih.gov/pmc/articles/30228">Free Full Text </a></span></li><li><a name=ref-92 class=n-a></a><span class=label>92. </span>&nbsp;<span class=citation><a name=d4383e3576 class=n-a></a>Matsumoto K, Pinna G, Puia G, <i> et al.</i>: Social isolation stress-induced aggression in mice: a model to study the pharmacology of neurosteroidogenesis. <i>Stress.</i> 2005; <b>8</b>(2): 85–93. <a target=xrefwindow id=d4383e3587 href="http://www.ncbi.nlm.nih.gov/pubmed/16019600">PubMed Abstract </a> | <a target=xrefwindow id=d4383e3590 href="https://doi.org/10.1080/10253890500159022">Publisher Full Text </a></span></li><li><a name=ref-93 class=n-a></a><span class=label>93. </span>&nbsp;<span class=citation><a name=d4383e3599 class=n-a></a>Serra M, Pisu MG, Littera M, <i> et al.</i>: Social isolation-induced decreases in both the abundance of neuroactive steroids and GABA<sub>A</sub> receptor function in rat brain. <i>J Neurochem.</i> 2000; <b>75</b>(2): 732–40. <a target=xrefwindow id=d4383e3613 href="http://www.ncbi.nlm.nih.gov/pubmed/10899949">PubMed Abstract </a> | <a target=xrefwindow id=d4383e3617 href="https://doi.org/10.1046/j.1471-4159.2000.0750732.x">Publisher Full Text </a></span></li><li><a name=ref-94 class=n-a></a><span class=label>94. </span>&nbsp;<span class=citation><a name=d4383e3626 class=n-a></a>Pibiri F, Nelson M, Guidotti A, <i> et al.</i>: Decreased corticolimbic allopregnanolone expression during social isolation enhances contextual fear: A model relevant for posttraumatic stress disorder. <i>Proc Natl Acad Sci U S A.</i> 2008; <b>105</b>(14): 5567–72. <a target=xrefwindow id=d4383e3637 href="http://www.ncbi.nlm.nih.gov/pubmed/18391192">PubMed Abstract </a> | <a target=xrefwindow id=d4383e3640 href="https://doi.org/10.1073/pnas.0801853105">Publisher Full Text </a> | <a target=xrefwindow id=d4383e3644 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2291140">Free Full Text </a></span></li><li><a name=ref-95 class=n-a></a><span class=label>95. </span>&nbsp;<span class=citation><a name=d4383e3653 class=n-a></a>Agís-Balboa RC, Pinna G, Pibiri F, <i> et al.</i>: Down-regulation of neurosteroid biosynthesis in corticolimbic circuits mediates social isolation-induced behavior in mice. <i>Proc Natl Acad Sci U S A.</i> 2007; <b>104</b>(47): 18736–41. <a target=xrefwindow id=d4383e3664 href="http://www.ncbi.nlm.nih.gov/pubmed/18003893">PubMed Abstract </a> | <a target=xrefwindow id=d4383e3667 href="https://doi.org/10.1073/pnas.0709419104">Publisher Full Text </a> | <a target=xrefwindow id=d4383e3671 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2141846">Free Full Text </a></span></li><li><a name=ref-96 class=n-a></a><span class=label>96. </span>&nbsp;<span class=citation><a name=d4383e3681 class=n-a></a>Bortolato M, Devoto P, Roncada P, <i> et al.</i>: Isolation rearing-induced reduction of brain 5α-reductase expression: relevance to dopaminergic impairments. <i>Neuropharmacology.</i> 2011; <b>60</b>(7–8): 1301–8. <a target=xrefwindow id=d4383e3692 href="http://www.ncbi.nlm.nih.gov/pubmed/21256141">PubMed Abstract </a> | <a target=xrefwindow id=d4383e3695 href="https://doi.org/10.1016/j.neuropharm.2011.01.013">Publisher Full Text </a></span></li><li><a name=ref-97 class=n-a></a><span class=label>97. </span>&nbsp;<span class=citation><a name=d4383e3704 class=n-a></a>Nelson M, Pinna G: S-norfluoxetine microinfused into the basolateral amygdala increases allopregnanolone levels and reduces aggression in socially isolated mice. <i>Neuropharmacology.</i> 2011; <b>60</b>(7–8): 1154–9. <a target=xrefwindow id=d4383e3712 href="http://www.ncbi.nlm.nih.gov/pubmed/20971127">PubMed Abstract </a> | <a target=xrefwindow id=d4383e3715 href="https://doi.org/10.1016/j.neuropharm.2010.10.011">Publisher Full Text </a> | <a target=xrefwindow id=d4383e3718 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3042033">Free Full Text </a></span></li><li><a name=ref-98 class=n-a></a><span class=label>98. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/13237956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4383e3727 class=n-a></a>Snyder JS, Soumier A, Brewer M, <i> et al.</i>: Adult hippocampal neurogenesis buffers stress responses and depressive behaviour. <i>Nature.</i> 2011; <b>476</b>(7361): 458–61. <a target=xrefwindow id=d4383e3738 href="http://www.ncbi.nlm.nih.gov/pubmed/21814201">PubMed Abstract </a> | <a target=xrefwindow id=d4383e3741 href="https://doi.org/10.1038/nature10287">Publisher Full Text </a> | <a target=xrefwindow id=d4383e3745 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3162077">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/13237956">F1000 Recommendation</a></span></li><li><a name=ref-99 class=n-a></a><span class=label>99. </span>&nbsp;<span class=citation><a name=d4383e3758 class=n-a></a>Evans J, Sun Y, McGregor A, <i> et al.</i>: Allopregnanolone regulates neurogenesis and depressive/anxiety-like behaviour in a social isolation rodent model of chronic stress. <i>Neuropharmacology.</i> 2012; <b>63</b>(8): 1315–26. <a target=xrefwindow id=d4383e3769 href="http://www.ncbi.nlm.nih.gov/pubmed/22939998">PubMed Abstract </a> | <a target=xrefwindow id=d4383e3772 href="https://doi.org/10.1016/j.neuropharm.2012.08.012">Publisher Full Text </a></span></li><li><a name=ref-100 class=n-a></a><span class=label>100. </span>&nbsp;<span class=citation><a name=d4383e3781 class=n-a></a>Wang JM, Singh C, Liu L, <i> et al.</i>: Allopregnanolone reverses neurogenic and cognitive deficits in mouse model of Alzheimer's disease. <i>Proc Natl Acad Sci U S A.</i> 2010; <b>107</b>(14): 6498–503. <a target=xrefwindow id=d4383e3792 href="http://www.ncbi.nlm.nih.gov/pubmed/20231471">PubMed Abstract </a> | <a target=xrefwindow id=d4383e3795 href="https://doi.org/10.1073/pnas.1001422107">Publisher Full Text </a> | <a target=xrefwindow id=d4383e3799 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2851948">Free Full Text </a></span></li><li><a name=ref-101 class=n-a></a><span class=label>101. </span>&nbsp;<span class=citation><a name=d4383e3808 class=n-a></a>Singh C, Liu L, Wang JM, <i> et al.</i>: Allopregnanolone restores hippocampal-dependent learning and memory and neural progenitor survival in aging 3xTgAD and nonTg mice. <i>Neurobiol Aging.</i> 2012; <b>33</b>(8): 1493–506. <a target=xrefwindow id=d4383e3819 href="http://www.ncbi.nlm.nih.gov/pubmed/21803451">PubMed Abstract </a> | <a target=xrefwindow id=d4383e3822 href="https://doi.org/10.1016/j.neurobiolaging.2011.06.008">Publisher Full Text </a> | <a target=xrefwindow id=d4383e3826 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3232295">Free Full Text </a></span></li><li><a name=ref-102 class=n-a></a><span class=label>102. </span>&nbsp;<span class=citation><a name=d4383e3836 class=n-a></a>Schüle C, Nothdurfter C, Rupprecht R: The role of allopregnanolone in depression and anxiety. <i>Prog Neurobiol.</i> 2014; <b>113</b>: 79–87. <a target=xrefwindow id=d4383e3844 href="http://www.ncbi.nlm.nih.gov/pubmed/24215796">PubMed Abstract </a> | <a target=xrefwindow id=d4383e3847 href="https://doi.org/10.1016/j.pneurobio.2013.09.003">Publisher Full Text </a></span></li><li><a name=ref-103 class=n-a></a><span class=label>103. </span>&nbsp;<span class=citation><a name=d4383e3856 class=n-a></a>Engin E, Treit D: The anxiolytic-like effects of allopregnanolone vary as a function of intracerebral microinfusion site: the amygdala, medial prefrontal cortex, or hippocampus. <i>Behav Pharmacol.</i> 2007; <b>18</b>(5–6): 461–70. <a target=xrefwindow id=d4383e3864 href="http://www.ncbi.nlm.nih.gov/pubmed/17762514">PubMed Abstract </a> | <a target=xrefwindow id=d4383e3867 href="https://doi.org/10.1097/FBP.0b013e3282d28f6f">Publisher Full Text </a></span></li><li><a name=ref-104 class=n-a></a><span class=label>104. </span>&nbsp;<span class=citation><a name=d4383e3876 class=n-a></a>Shirayama Y, Muneoka K, Fukumoto M, <i> et al.</i>: Infusions of allopregnanolone into the hippocampus and amygdala, but not into the nucleus accumbens and medial prefrontal cortex, produce antidepressant effects on the learned helplessness rats. <i>Hippocampus.</i> 2011; <b>21</b>(10): 1105–13. <a target=xrefwindow id=d4383e3887 href="http://www.ncbi.nlm.nih.gov/pubmed/20623764">PubMed Abstract </a> | <a target=xrefwindow id=d4383e3890 href="https://doi.org/10.1002/hipo.20824">Publisher Full Text </a></span></li><li><a name=ref-105 class=n-a></a><span class=label>105. </span>&nbsp;<span class=citation><a name=d4383e3899 class=n-a></a>Möhler H: The GABA system in anxiety and depression and its therapeutic potential. <i>Neuropharmacology.</i> 2012; <b>62</b>(1): 42–53. <a target=xrefwindow id=d4383e3907 href="http://www.ncbi.nlm.nih.gov/pubmed/21889518">PubMed Abstract </a> | <a target=xrefwindow id=d4383e3910 href="https://doi.org/10.1016/j.neuropharm.2011.08.040">Publisher Full Text </a></span></li><li><a name=ref-106 class=n-a></a><span class=label>106. </span>&nbsp;<span class=citation><a name=d4383e3919 class=n-a></a>Nin MS, Martinez LA, Pibiri F, <i> et al.</i>: Neurosteroids reduce social isolation-induced behavioral deficits: a proposed link with neurosteroid-mediated upregulation of BDNF expression. <i>Front Endocrinol (Lausanne).</i> 2011; <b>2</b>: 73. <a target=xrefwindow id=d4383e3930 href="http://www.ncbi.nlm.nih.gov/pubmed/22649384">PubMed Abstract </a> | <a target=xrefwindow id=d4383e3933 href="https://doi.org/10.3389/fendo.2011.00073">Publisher Full Text </a> | <a target=xrefwindow id=d4383e3937 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3355888">Free Full Text </a></span></li><li><a name=ref-107 class=n-a></a><span class=label>107. </span>&nbsp;<span class=citation><a name=d4383e3946 class=n-a></a>Uzunova V, Wrynn AS, Kinnunen A, <i> et al.</i>: Chronic antidepressants reverse cerebrocortical allopregnanolone decline in the olfactory-bulbectomized rat. <i>Eur J Pharmacol.</i> 2004; <b>486</b>(1): 31–4. <a target=xrefwindow id=d4383e3957 href="http://www.ncbi.nlm.nih.gov/pubmed/14751405">PubMed Abstract </a> | <a target=xrefwindow id=d4383e3960 href="https://doi.org/10.1016/j.ejphar.2003.12.002">Publisher Full Text </a></span></li><li><a name=ref-108 class=n-a></a><span class=label>108. </span>&nbsp;<span class=citation><a name=d4383e3970 class=n-a></a>Guidotti A, Costa E: Can the antidysphoric and anxiolytic profiles of selective serotonin reuptake inhibitors be related to their ability to increase brain 3 alpha, 5 alpha-tetrahydroprogesterone (allopregnanolone) availability? <i>Biol Psychiatry.</i> 1998; <b>44</b>(9): 865–73. <a target=xrefwindow id=d4383e3978 href="http://www.ncbi.nlm.nih.gov/pubmed/9807641">PubMed Abstract </a> | <a target=xrefwindow id=d4383e3981 href="https://doi.org/10.1016/S0006-3223(98)00070-5">Publisher Full Text </a></span></li><li><a name=ref-109 class=n-a></a><span class=label>109. </span>&nbsp;<span class=citation><a name=d4383e3990 class=n-a></a>Romeo E, Ströhle A, Spalletta G, <i> et al.</i>: Effects of antidepressant treatment on neuroactive steroids in major depression. <i>Am J Psychiatry.</i> 1998; <b>155</b>(7): 910–3. <a target=xrefwindow id=d4383e4001 href="http://www.ncbi.nlm.nih.gov/pubmed/9659856">PubMed Abstract </a> | <a target=xrefwindow id=d4383e4004 href="https://doi.org/10.1176/ajp.155.7.910">Publisher Full Text </a></span></li><li><a name=ref-110 class=n-a></a><span class=label>110. </span>&nbsp;<span class=citation><a name=d4383e4013 class=n-a></a>Griffin LD, Mellon SH: Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes. <i>Proc Natl Acad Sci U S A.</i> 1999; <b>96</b>(23): 13512–7. <a target=xrefwindow id=d4383e4021 href="http://www.ncbi.nlm.nih.gov/pubmed/10557352">PubMed Abstract </a> | <a target=xrefwindow id=d4383e4024 href="https://doi.org/10.1073/pnas.96.23.13512">Publisher Full Text </a> | <a target=xrefwindow id=d4383e4027 href="http://www.ncbi.nlm.nih.gov/pmc/articles/23979">Free Full Text </a></span></li><li><a name=ref-111 class=n-a></a><span class=label>111. </span>&nbsp;<span class=citation><a name=d4383e4036 class=n-a></a>Fry JP, Li KY, Devall AJ, <i> et al.</i>: Fluoxetine elevates allopregnanolone in female rat brain but inhibits a steroid microsomal dehydrogenase rather than activating an aldo-keto reductase. <i>Br J Pharmacol.</i> 2014; <b>171</b>(24): 5870–80. <a target=xrefwindow id=d4383e4047 href="http://www.ncbi.nlm.nih.gov/pubmed/25161074">PubMed Abstract </a> | <a target=xrefwindow id=d4383e4050 href="https://doi.org/10.1111/bph.12891">Publisher Full Text </a> | <a target=xrefwindow id=d4383e4054 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4290723">Free Full Text </a></span></li><li><a name=ref-112 class=n-a></a><span class=label>112. </span>&nbsp;<span class=citation><a name=d4383e4063 class=n-a></a>Field T: Postpartum depression effects on early interactions, parenting, and safety practices: a review. <i>Infant Behav Dev.</i> 2010; <b>33</b>(1): 1–6. <a target=xrefwindow id=d4383e4071 href="http://www.ncbi.nlm.nih.gov/pubmed/19962196">PubMed Abstract </a> | <a target=xrefwindow id=d4383e4074 href="https://doi.org/10.1016/j.infbeh.2009.10.005">Publisher Full Text </a> | <a target=xrefwindow id=d4383e4077 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2819576">Free Full Text </a></span></li><li><a name=ref-113 class=n-a></a><span class=label>113. </span>&nbsp;<span class=citation><a name=d4383e4086 class=n-a></a>Kim DR, Epperson CN, Weiss AR, <i> et al.</i>: Pharmacotherapy of postpartum depression: an update. <i>Expert Opin Pharmacother.</i> 2014; <b>15</b>(9): 1223–34. <a target=xrefwindow id=d4383e4097 href="http://www.ncbi.nlm.nih.gov/pubmed/24773410">PubMed Abstract </a> | <a target=xrefwindow id=d4383e4100 href="https://doi.org/10.1517/14656566.2014.911842">Publisher Full Text </a> | <a target=xrefwindow id=d4383e4104 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4073803">Free Full Text </a></span></li><li><a name=ref-114 class=n-a></a><span class=label>114. </span>&nbsp;<span class=citation><a name=d4383e4114 class=n-a></a>Deligiannidis KM, Sikoglu EM, Shaffer SA, <i> et al.</i>: GABAergic neuroactive steroids and resting-state functional connectivity in postpartum depression: a preliminary study. <i>J Psychiatr Res.</i> 2013; <b>47</b>(6): 816–28. <a target=xrefwindow id=d4383e4125 href="http://www.ncbi.nlm.nih.gov/pubmed/23499388">PubMed Abstract </a> | <a target=xrefwindow id=d4383e4128 href="https://doi.org/10.1016/j.jpsychires.2013.02.010">Publisher Full Text </a> | <a target=xrefwindow id=d4383e4132 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3983790">Free Full Text </a></span></li><li><a name=ref-115 class=n-a></a><span class=label>115. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734616034"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4383e4141 class=n-a></a>Melón L, Hammond R, Lewis M, <i> et al.</i>: A Novel, Synthetic, Neuroactive Steroid Is Effective at Decreasing Depression-Like Behaviors and Improving Maternal Care in Preclinical Models of Postpartum Depression. <i>Front Endocrinol (Lausanne).</i> 2018; <b>9</b>: 703. <a target=xrefwindow id=d4383e4152 href="http://www.ncbi.nlm.nih.gov/pubmed/30532739">PubMed Abstract </a> | <a target=xrefwindow id=d4383e4155 href="https://doi.org/10.3389/fendo.2018.00703">Publisher Full Text </a> | <a target=xrefwindow id=d4383e4159 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6265503">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734616034">F1000 Recommendation</a></span></li><li><a name=ref-116 class=n-a></a><span class=label>116. </span>&nbsp;<span class=citation><a name=d4383e4172 class=n-a></a>Schiller CE, Schmidt PJ, Rubinow DR: Allopregnanolone as a mediator of affective switching in reproductive mood disorders. <i>Psychopharmacology (Berl).</i> 2014; <b>231</b>(17): 3557–67. <a target=xrefwindow id=d4383e4180 href="http://www.ncbi.nlm.nih.gov/pubmed/24846476">PubMed Abstract </a> | <a target=xrefwindow id=d4383e4183 href="https://doi.org/10.1007/s00213-014-3599-x">Publisher Full Text </a> | <a target=xrefwindow id=d4383e4186 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4135022">Free Full Text </a></span></li><li><a name=ref-117 class=n-a></a><span class=label>117. </span>&nbsp;<span class=citation><a name=d4383e4195 class=n-a></a>Schiller CE, Meltzer-Brody S, Rubinow DR: The role of reproductive hormones in postpartum depression. <i>CNS Spectr.</i> 2015; <b>20</b>(1): 48–59. <a target=xrefwindow id=d4383e4203 href="http://www.ncbi.nlm.nih.gov/pubmed/25263255">PubMed Abstract </a> | <a target=xrefwindow id=d4383e4206 href="https://doi.org/10.1017/S1092852914000480">Publisher Full Text </a> | <a target=xrefwindow id=d4383e4209 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4363269">Free Full Text </a></span></li><li><a name=ref-118 class=n-a></a><span class=label>118. </span>&nbsp;<span class=citation><a name=d4383e4218 class=n-a></a>Moses-Kolko EL, Perlman SB, Wisner KL, <i> et al.</i>: Abnormally reduced dorsomedial prefrontal cortical activity and effective connectivity with amygdala in response to negative emotional faces in postpartum depression. <i>Am J Psychiatry.</i> 2010; <b>167</b>(11): 1373–80. <a target=xrefwindow id=d4383e4229 href="http://www.ncbi.nlm.nih.gov/pubmed/20843875">PubMed Abstract </a> | <a target=xrefwindow id=d4383e4232 href="https://doi.org/10.1176/appi.ajp.2010.09081235">Publisher Full Text </a> | <a target=xrefwindow id=d4383e4236 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3293151">Free Full Text </a></span></li><li><a name=ref-119 class=n-a></a><span class=label>119. </span>&nbsp;<span class=citation><a name=d4383e4245 class=n-a></a>Bloch M, Schmidt PJ, Danaceau M, <i> et al.</i>: Effects of gonadal steroids in women with a history of postpartum depression. <i>Am J Psychiatry.</i> 2000; <b>157</b>(6): 924–30. <a target=xrefwindow id=d4383e4256 href="http://www.ncbi.nlm.nih.gov/pubmed/10831472">PubMed Abstract </a> | <a target=xrefwindow id=d4383e4259 href="https://doi.org/10.1176/appi.ajp.157.6.924">Publisher Full Text </a></span></li><li><a name=ref-120 class=n-a></a><span class=label>120. </span>&nbsp;<span class=citation><a name=d4383e4269 class=n-a></a>MacKenzie G, Maguire J: The role of ovarian hormone-derived neurosteroids on the regulation of GABA<sub>A</sub> receptors in affective disorders. <i>Psychopharmacology (Berl).</i> 2014; <b>231</b>(17): 3333–42. <a target=xrefwindow id=d4383e4280 href="http://www.ncbi.nlm.nih.gov/pubmed/24402140">PubMed Abstract </a> | <a target=xrefwindow id=d4383e4283 href="https://doi.org/10.1007/s00213-013-3423-z">Publisher Full Text </a> | <a target=xrefwindow id=d4383e4287 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4090295">Free Full Text </a></span></li><li><a name=ref-121 class=n-a></a><span class=label>121. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1119494"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4383e4296 class=n-a></a>Maguire J, Mody I: GABA<sub>A</sub>R plasticity during pregnancy: relevance to postpartum depression. <i>Neuron.</i> 2008; <b>59</b>(2): 207–13. <a target=xrefwindow id=d4383e4307 href="http://www.ncbi.nlm.nih.gov/pubmed/18667149">PubMed Abstract </a> | <a target=xrefwindow id=d4383e4310 href="https://doi.org/10.1016/j.neuron.2008.06.019">Publisher Full Text </a> | <a target=xrefwindow id=d4383e4314 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2875248">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1119494">F1000 Recommendation</a></span></li><li><a name=ref-122 class=n-a></a><span class=label>122. </span>&nbsp;<span class=citation><a name=d4383e4327 class=n-a></a>Biggio G, Cristina Mostallino M, Follesa P, <i> et al.</i>: GABA<sub>A</sub> receptor function and gene expression during pregnancy and postpartum. <i>Int Rev Neurobiol.</i> 2009; <b>85</b>: 73–94. <a target=xrefwindow id=d4383e4341 href="http://www.ncbi.nlm.nih.gov/pubmed/19607962">PubMed Abstract </a> | <a target=xrefwindow id=d4383e4345 href="https://doi.org/10.1016/S0074-7742(09)85006-X">Publisher Full Text </a></span></li><li><a name=ref-123 class=n-a></a><span class=label>123. </span>&nbsp;<span class=citation><a name=d4383e4354 class=n-a></a>Concas A, Mostallino MC, Porcu P, <i> et al.</i>: Role of brain allopregnanolone in the plasticity of gamma-aminobutyric acid type A receptor in rat brain during pregnancy and after delivery. <i>Proc Natl Acad Sci U S A.</i> 1998; <b>95</b>(22): 13284–9. <a target=xrefwindow id=d4383e4365 href="http://www.ncbi.nlm.nih.gov/pubmed/9789080">PubMed Abstract </a> | <a target=xrefwindow id=d4383e4368 href="https://doi.org/10.1073/pnas.95.22.13284">Publisher Full Text </a> | <a target=xrefwindow id=d4383e4372 href="http://www.ncbi.nlm.nih.gov/pmc/articles/23784">Free Full Text </a></span></li><li><a name=ref-124 class=n-a></a><span class=label>124. </span>&nbsp;<span class=citation><a name=d4383e4381 class=n-a></a>Brunton PJ, Russell JA: Allopregnanolone and suppressed hypothalamo-pituitary-adrenal axis stress responses in late pregnancy in the rat. <i>Stress.</i> 2011; <b>14</b>(1): 6–12. <a target=xrefwindow id=d4383e4389 href="http://www.ncbi.nlm.nih.gov/pubmed/20666638">PubMed Abstract </a> | <a target=xrefwindow id=d4383e4392 href="https://doi.org/10.3109/10253890.2010.482628">Publisher Full Text </a></span></li><li><a name=ref-125 class=n-a></a><span class=label>125. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727722198"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4383e4401 class=n-a></a>Kanes S, Colquhoun H, Gunduz-Bruce H, <i> et al.</i>: Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial. <i>Lancet.</i> 2017; <b>390</b>(10093): 480–9. <a target=xrefwindow id=d4383e4412 href="http://www.ncbi.nlm.nih.gov/pubmed/28619476">PubMed Abstract </a> | <a target=xrefwindow id=d4383e4415 href="https://doi.org/10.1016/S0140-6736(17)31264-3">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727722198">F1000 Recommendation</a></span></li><li><a name=ref-126 class=n-a></a><span class=label>126. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733945711"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4383e4429 class=n-a></a>Meltzer-Brody S, Colquhoun H, Riesenberg R, <i> et al.</i>: Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials. <i>Lancet.</i> 2018; <b>392</b>(10152): 1058–70. <a target=xrefwindow id=d4383e4440 href="http://www.ncbi.nlm.nih.gov/pubmed/30177236">PubMed Abstract </a> | <a target=xrefwindow id=d4383e4443 href="https://doi.org/10.1016/S0140-6736(18)31551-4">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733945711">F1000 Recommendation</a></span></li><li><a name=ref-127 class=n-a></a><span class=label>127. </span>&nbsp;<span class=citation><a name=d4383e4456 class=n-a></a>Sage Therapeutics: Brexanolone Injection, for Intravenous Use: Sponsor Briefing Document. Joint Meeting of the Psychopharmacologic Drug Advisory Committee and Drug Safety and Risk Management Advisory Committee; November 2, 2018. <a target=xrefwindow id=d4383e4458 href="https://www.fda.gov/media/121348/download">Reference Source</a></span></li><li><a name=ref-128 class=n-a></a><span class=label>128. </span>&nbsp;<span class=citation><a name=d4383e4467 class=n-a></a>Luisi S, Petraglia F, Benedetto C, <i> et al.</i>: Serum allopregnanolone levels in pregnant women: changes during pregnancy, at delivery, and in hypertensive patients. <i>J Clin Endocrinol Metab.</i> 2000; <b>85</b>(7): 2429–33. <a target=xrefwindow id=d4383e4478 href="http://www.ncbi.nlm.nih.gov/pubmed/10902789">PubMed Abstract </a> | <a target=xrefwindow id=d4383e4481 href="https://doi.org/10.1210/jcem.85.7.6675">Publisher Full Text </a></span></li><li><a name=ref-129 class=n-a></a><span class=label>129. </span>&nbsp;<span class=citation><a name=d4383e4490 class=n-a></a>U.S. Food and Drug Administration: FDA approves first treatment for post-partum depression. March 19, 2019. <a target=xrefwindow id=d4383e4492 href="https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-post-partum-depression">Reference Source</a></span></li><li><a name=ref-130 class=n-a></a><span class=label>130. </span>&nbsp;<span class=citation><a name=d4383e4501 class=n-a></a>Harris B, Lovett L, Smith J, <i> et al.</i>: Cardiff puerperal mood and hormone study. III. Postnatal depression at 5 to 6 weeks postpartum, and its hormonal correlates across the peripartum period. <i>Br J Psychiatry.</i> 1996; <b>168</b>(6): 739–44. <a target=xrefwindow id=d4383e4512 href="http://www.ncbi.nlm.nih.gov/pubmed/8773817">PubMed Abstract </a> | <a target=xrefwindow id=d4383e4515 href="https://doi.org/10.1192/bjp.168.6.739">Publisher Full Text </a></span></li><li><a name=ref-131 class=n-a></a><span class=label>131. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727847766"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4383e4524 class=n-a></a>Martinez Botella G, Salituro FG, Harrison BL, <i> et al.</i>: Neuroactive Steroids. 2. 3α-Hydroxy-3β-methyl-21-(4-cyano-1<i>H</i>-pyrazol-1'-yl)-19-nor-5β-pregnan-20-one (SAGE-217): A Clinical Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (γ-Aminobutyric Acid)<sub>A</sub> Receptor. <i>J Med Chem.</i> 2017; <b>60</b>(18): 7810–9. <a target=xrefwindow id=d4383e4542 href="http://www.ncbi.nlm.nih.gov/pubmed/28753313">PubMed Abstract </a> | <a target=xrefwindow id=d4383e4545 href="https://doi.org/10.1021/acs.jmedchem.7b00846">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727847766">F1000 Recommendation</a></span></li><li><a name=ref-132 class=n-a></a><span class=label>132. </span>&nbsp;<span class=citation><a name=d4383e4559 class=n-a></a>Wang JM, Johnston PB, Ball BG, <i> et al.</i>: The neurosteroid allopregnanolone promotes proliferation of rodent and human neural progenitor cells and regulates cell-cycle gene and protein expression. <i>J Neurosci.</i> 2005; <b>25</b>(19): 4706–18. <a target=xrefwindow id=d4383e4570 href="http://www.ncbi.nlm.nih.gov/pubmed/15888646">PubMed Abstract </a> | <a target=xrefwindow id=d4383e4573 href="https://doi.org/10.1523/JNEUROSCI.4520-04.2005">Publisher Full Text </a></span></li><li><a name=ref-133 class=n-a></a><span class=label>133. </span>&nbsp;<span class=citation><a name=d4383e4582 class=n-a></a>Russo SJ, Murrough JW, Han MH, <i> et al.</i>: Neurobiology of resilience. <i>Nat Neurosci.</i> 2012; <b>15</b>(11): 1475–84. <a target=xrefwindow id=d4383e4593 href="http://www.ncbi.nlm.nih.gov/pubmed/23064380">PubMed Abstract </a> | <a target=xrefwindow id=d4383e4596 href="https://doi.org/10.1038/nn.3234">Publisher Full Text </a> | <a target=xrefwindow id=d4383e4600 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3580862">Free Full Text </a></span></li><li><a name=ref-134 class=n-a></a><span class=label>134. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1097988"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4383e4609 class=n-a></a>Krishnan V, Han MH, Graham DL, <i> et al.</i>: Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. <i>Cell.</i> 2007; <b>131</b>(2): 391–404. <a target=xrefwindow id=d4383e4620 href="http://www.ncbi.nlm.nih.gov/pubmed/17956738">PubMed Abstract </a> | <a target=xrefwindow id=d4383e4623 href="https://doi.org/10.1016/j.cell.2007.09.018">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1097988">F1000 Recommendation</a></span></li><li><a name=ref-135 class=n-a></a><span class=label>135. </span>&nbsp;<span class=citation><a name=d4383e4636 class=n-a></a>Han MH, Nestler EJ: Neural Substrates of Depression and Resilience. <i>Neurotherapeutics.</i> 2017; <b>14</b>(3): 677–86. <a target=xrefwindow id=d4383e4644 href="http://www.ncbi.nlm.nih.gov/pubmed/28397115">PubMed Abstract </a> | <a target=xrefwindow id=d4383e4647 href="https://doi.org/10.1007/s13311-017-0527-x">Publisher Full Text </a> | <a target=xrefwindow id=d4383e4650 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5509625">Free Full Text </a></span></li><li><a name=ref-136 class=n-a></a><span class=label>136. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718355157"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4383e4659 class=n-a></a>Friedman AK, Walsh JJ, Juarez B, <i> et al.</i>: Enhancing depression mechanisms in midbrain dopamine neurons achieves homeostatic resilience. <i>Science.</i> 2014; <b>344</b>(6181): 313–9. <a target=xrefwindow id=d4383e4670 href="http://www.ncbi.nlm.nih.gov/pubmed/24744379">PubMed Abstract </a> | <a target=xrefwindow id=d4383e4673 href="https://doi.org/10.1126/science.1249240">Publisher Full Text </a> | <a target=xrefwindow id=d4383e4677 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4334447">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718355157">F1000 Recommendation</a></span></li><li><a name=ref-137 class=n-a></a><span class=label>137. </span>&nbsp;<span class=citation><a name=d4383e4690 class=n-a></a>Cao JL, Covington HE 3rd, Friedman AK, <i> et al.</i>: Mesolimbic dopamine neurons in the brain reward circuit mediate susceptibility to social defeat and antidepressant action. <i>J Neurosci.</i> 2010; <b>30</b>(49): 16453–8. <a target=xrefwindow id=d4383e4701 href="http://www.ncbi.nlm.nih.gov/pubmed/21147984">PubMed Abstract </a> | <a target=xrefwindow id=d4383e4704 href="https://doi.org/10.1523/JNEUROSCI.3177-10.2010">Publisher Full Text </a> | <a target=xrefwindow id=d4383e4708 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3061337">Free Full Text </a></span></li><li><a name=ref-138 class=n-a></a><span class=label>138. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/3674966"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4383e4718 class=n-a></a>Vialou V, Robison AJ, Laplant QC, <i> et al.</i>: DeltaFosB in brain reward circuits mediates resilience to stress and antidepressant responses. <i>Nat Neurosci.</i> 2010; <b>13</b>(6): 745–52. <a target=xrefwindow id=d4383e4729 href="http://www.ncbi.nlm.nih.gov/pubmed/20473292">PubMed Abstract </a> | <a target=xrefwindow id=d4383e4732 href="https://doi.org/10.1038/nn.2551">Publisher Full Text </a> | <a target=xrefwindow id=d4383e4736 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2895556">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/3674966">F1000 Recommendation</a></span></li><li><a name=ref-139 class=n-a></a><span class=label>139. </span>&nbsp;<span class=citation><a name=d4383e4749 class=n-a></a>Zhu Z, Wang G, Ma K, <i> et al.</i>: GABAergic neurons in nucleus accumbens are correlated to resilience and vulnerability to chronic stress for major depression. <i>Oncotarget.</i> 2017; <b>8</b>(22): 35933–45. <a target=xrefwindow id=d4383e4760 href="http://www.ncbi.nlm.nih.gov/pubmed/28415589">PubMed Abstract </a> | <a target=xrefwindow id=d4383e4763 href="https://doi.org/10.18632/oncotarget.16411">Publisher Full Text </a> | <a target=xrefwindow id=d4383e4767 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5482628">Free Full Text </a></span></li><li><a name=ref-140 class=n-a></a><span class=label>140. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727680720"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4383e4776 class=n-a></a>Qu Y, Yang C, Ren Q, <i> et al.</i>: Regional differences in dendritic spine density confer resilience to chronic social defeat stress. <i>Acta Neuropsychiatr.</i> 2018; <b>30</b>(2): 117–22. <a target=xrefwindow id=d4383e4787 href="http://www.ncbi.nlm.nih.gov/pubmed/28566105">PubMed Abstract </a> | <a target=xrefwindow id=d4383e4790 href="https://doi.org/10.1017/neu.2017.16">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727680720">F1000 Recommendation</a></span></li><li><a name=ref-141 class=n-a></a><span class=label>141. </span>&nbsp;<span class=citation><a name=d4383e4803 class=n-a></a>Anacker C, O'Donnell KJ, Meaney MJ: Early life adversity and the epigenetic programming of hypothalamic-pituitary-adrenal function. <i>Dialogues Clin Neurosci.</i> 2014; <b>16</b>(3): 321–33. <a target=xrefwindow id=d4383e4811 href="http://www.ncbi.nlm.nih.gov/pubmed/25364283">PubMed Abstract </a> | <a target=xrefwindow id=d4383e4814 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4214175">Free Full Text </a></span></li><li><a name=ref-142 class=n-a></a><span class=label>142. </span>&nbsp;<span class=citation><a name=d4383e4823 class=n-a></a>Weaver IC, Champagne FA, Brown SE, <i> et al.</i>: Reversal of maternal programming of stress responses in adult offspring through methyl supplementation: altering epigenetic marking later in life. <i>J Neurosci.</i> 2005; <b>25</b>(47): 11045–54. <a target=xrefwindow id=d4383e4834 href="http://www.ncbi.nlm.nih.gov/pubmed/16306417">PubMed Abstract </a> | <a target=xrefwindow id=d4383e4837 href="https://doi.org/10.1523/JNEUROSCI.3652-05.2005">Publisher Full Text </a></span></li><li><a name=ref-143 class=n-a></a><span class=label>143. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733511685"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4383e4846 class=n-a></a>Anacker C, Luna VM, Stevens GS, <i> et al.</i>: Hippocampal neurogenesis confers stress resilience by inhibiting the ventral dentate gyrus. <i>Nature.</i> 2018; <b>559</b>(7712): 98–102. <a target=xrefwindow id=d4383e4857 href="http://www.ncbi.nlm.nih.gov/pubmed/29950730">PubMed Abstract </a> | <a target=xrefwindow id=d4383e4860 href="https://doi.org/10.1038/s41586-018-0262-4">Publisher Full Text </a> | <a target=xrefwindow id=d4383e4864 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6118212">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733511685">F1000 Recommendation</a></span></li><li><a name=ref-144 class=n-a></a><span class=label>144. </span>&nbsp;<span class=citation><a name=d4383e4878 class=n-a></a>Drew LJ, Kheirbek MA, Luna VM, <i> et al.</i>: Activation of local inhibitory circuits in the dentate gyrus by adult-born neurons. <i>Hippocampus.</i> 2016; <b>26</b>(6): 763–78. <a target=xrefwindow id=d4383e4889 href="http://www.ncbi.nlm.nih.gov/pubmed/26662922">PubMed Abstract </a> | <a target=xrefwindow id=d4383e4892 href="https://doi.org/10.1002/hipo.22557">Publisher Full Text </a> | <a target=xrefwindow id=d4383e4896 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4867135">Free Full Text </a></span></li><li><a name=ref-145 class=n-a></a><span class=label>145. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/731602723"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4383e4905 class=n-a></a>Laverty D, Thomas P, Field M, <i> et al.</i>: Crystal structures of a GABA<sub>A</sub>-receptor chimera reveal new endogenous neurosteroid-binding sites. <i>Nat Struct Mol Biol.</i> 2017; <b>24</b>(11): 977–85. <a target=xrefwindow id=d4383e4919 href="http://www.ncbi.nlm.nih.gov/pubmed/28967882">PubMed Abstract </a> | <a target=xrefwindow id=d4383e4923 href="https://doi.org/10.1038/nsmb.3477">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/731602723">F1000 Recommendation</a></span></li><li><a name=ref-146 class=n-a></a><span class=label>146. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/734101559"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4383e4936 class=n-a></a>Chen Q, Wells MM, Arjunan P, <i> et al.</i>: Structural basis of neurosteroid anesthetic action on GABA<sub>A</sub> receptors. <i>Nat Commun.</i> 2018; <b>9</b>(1): 3972. <a target=xrefwindow id=d4383e4950 href="http://www.ncbi.nlm.nih.gov/pubmed/30266951">PubMed Abstract </a> | <a target=xrefwindow id=d4383e4954 href="https://doi.org/10.1038/s41467-018-06361-4">Publisher Full Text </a> | <a target=xrefwindow id=d4383e4957 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6162318">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/734101559">F1000 Recommendation</a></span></li><li><a name=ref-147 class=n-a></a><span class=label>147. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/731932237"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d4383e4970 class=n-a></a>Miller PS, Scott S, Masiulis S, <i> et al.</i>: Structural basis for GABA<sub>A</sub> receptor potentiation by neurosteroids. <i>Nat Struct Mol Biol.</i> 2017; <b>24</b>(11): 986–92. <a target=xrefwindow id=d4383e4984 href="http://www.ncbi.nlm.nih.gov/pubmed/28991263">PubMed Abstract </a> | <a target=xrefwindow id=d4383e4988 href="https://doi.org/10.1038/nsmb.3484">Publisher Full Text </a> | <a target=xrefwindow id=d4383e4991 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6166781">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/731932237">F1000 Recommendation</a></span></li><li><a name=ref-148 class=n-a></a><span class=label>148. </span>&nbsp;<span class=citation><a name=d4383e5004 class=n-a></a>Masiulis S, Desai R, Uchański T, <i> et al.</i>: GABA<sub>A</sub> receptor signalling mechanisms revealed by structural pharmacology. <i>Nature.</i> 2019; <b>565</b>(7740): 454–9. <a target=xrefwindow id=d4383e5018 href="http://www.ncbi.nlm.nih.gov/pubmed/30602790">PubMed Abstract </a> | <a target=xrefwindow id=d4383e5022 href="https://doi.org/10.1038/s41586-018-0832-5">Publisher Full Text </a> | <a target=xrefwindow id=d4383e5025 href="http://www.ncbi.nlm.nih.gov/pmc/articles/6370056">Free Full Text </a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (2)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class=comments-list-container> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class="mversion ">VERSION 1</span> <span class="details u-ml--1">PUBLISHED 29 May 2019</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <ul class=all-comment-wrapper data-reportID=NONE data-versionID=1> <li class="comment-wrapper not-sortable " data-commentID=5226> <div class="one-comment version-comments "> <a name=article-comment-5226></a> <div class="f1r-article-desk commenter-role"> Author Response 12 Feb 2020 </div> <div> <span class=name>Bernhard Luscher</span><span class=name>, </span><span class=commenter-affiliation>Pennsylvania State University, University Park, USA</span> </div> <div class="f1r-article-mobile the-comment-date"> 12 Feb 2020 </div> <div class=f1r-article-mobile> <div class="article-pubinfo-mobile comments-section"> <span class="version-info-box comments"> Author Response </span> </div> </div> <div class="comment-content article-comment-list"> <span class=truncated-comment> That is a very good question. One idea is that anxiety is caused by the primary defect in neural inhibition and the ensuing increase in network excitability, which can be ... <span class="continue-reading-container response-and-comment">Continue reading</span> </span> <span class="full-comment hidden"> <span id=full-comment-original-5226 class=hidden>That is a very good question. One idea is that anxiety is caused by the primary defect in neural inhibition and the ensuing increase in network excitability, which can be readily reversed by drugs that potentiate GABAergic inhibition. By contrast, depression appears to involve additional chronic E:I imbalance-induced homeostatic downregulation of glutamate receptors and a corresponding loss of connectivity of principal cells. Such homeostatic downregulation of glutamatergic transmission is observed in mice with constitutive defects in GABAergic inhibition (Ren et al. 2016&nbsp;Biol Psychiatry 80, 467-468) as well as when animals are exposed to chronic stress (Yuen et al Neuron 73, 962-977).(for review see Luscher and Fuchs, 2015; Adv Pharmacol 73. 97-144). Both types of defects are reversed by ketamine-induced synaptogenesis for a prolonged period (Ren et al. op cit)</span> <div class=padding-bottom id=full-comment-5226>That is a very good question. One idea is that anxiety is caused by the primary defect in neural inhibition and the ensuing increase in network excitability, which can be readily reversed by drugs that potentiate GABAergic inhibition. By contrast, depression appears to involve additional chronic E:I imbalance-induced homeostatic downregulation of glutamate receptors and a corresponding loss of connectivity of principal cells. Such homeostatic downregulation of glutamatergic transmission is observed in mice with constitutive defects in GABAergic inhibition (Ren et al. 2016&nbsp;Biol Psychiatry 80, 467-468) as well as when animals are exposed to chronic stress (Yuen et al Neuron 73, 962-977).(for review see Luscher and Fuchs, 2015; Adv Pharmacol 73. 97-144). Both types of defects are reversed by ketamine-induced synaptogenesis for a prolonged period (Ren et al. op cit)</div> <span class="disclosures competing-interests-display padding-top"> <strong>Competing Interests:</strong> <span class=c-i-d>No competing interests were disclosed.</span> </span> <span class="hide-comment-container response-and-comment">Close</span> </span> <div class="report-concern-wrapper last-comment"> <a href="mailto:research@f1000.com?subject=Report a concern (18758) " class=report-a-concern-link>Report a concern</a> </div> </div> </div> </li> <li class="comment-wrapper not-sortable " data-commentID=5131> <div class="one-comment version-comments "> <a name=article-comment-5131></a> <div class="f1r-article-desk commenter-role"> Reader Comment 23 Dec 2019 </div> <div> <span class=name>Arnold Lippa</span><span class=name>, </span><span class=commenter-affiliation>RespireRx Pharmaceuticals Inc, New Jersey, USA</span> </div> <div class="f1r-article-mobile the-comment-date"> 23 Dec 2019 </div> <div class=f1r-article-mobile> <div class="article-pubinfo-mobile comments-section"> <span class="version-info-box comments"> Reader Comment </span> </div> </div> <div class="comment-content article-comment-list"> <span class=truncated-comment> Just a brief question - How do the authors explain the ability of benzodiazepines, well known positive allosteric modulators of the GABA<sub>A&nbsp;</sub>receptors, to improve the symptoms of anxiety but not ... <span class="continue-reading-container response-and-comment">Continue reading</span> </span> <span class="full-comment hidden"> <span id=full-comment-original-5131 class=hidden>Just a brief question - How do the authors explain the ability of benzodiazepines, well known positive allosteric modulators of the GABA<sub>A&nbsp;</sub>receptors, to improve the symptoms of anxiety but not MDD?</span> <div class=padding-bottom id=full-comment-5131>Just a brief question - How do the authors explain the ability of benzodiazepines, well known positive allosteric modulators of the GABA<sub>A&nbsp;</sub>receptors, to improve the symptoms of anxiety but not MDD?</div> <span class="disclosures competing-interests-display padding-top"> <strong>Competing Interests:</strong> <span class=c-i-d>No competing interests were disclosed.</span> </span> <span class="hide-comment-container response-and-comment">Close</span> </span> <div class="report-concern-wrapper last-comment"> <a href="mailto:research@f1000.com?subject=Report a concern (18758) " class=report-a-concern-link>Report a concern</a> </div> </div> </div> </li> <li class="comment-wrapper not-sortable button-wrapper"> <div class="one-comment version-comments add-the-comment"> <a href="/login?originalPath=/articles/8-751&scrollTo=add-new-comments" class=register-report-comment-button data-test-id=add-comment> <span class=f1r-article-desk><span class=contracted></span>Comment</span> <span class="f1r-article-mobile research-layout "> <button class="primary orange extra-padding comment-on-this-article">ADD YOUR COMMENT</button> </span> </a> </div> </li> </ul> </div> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Biology and Department of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, PA, 16802, USA<br/> <sup>2</sup> Center for Molecular Investigation of Neurological Disorders, The Huck Institutes for the Life Sciences, Pennsylvania State University, University Park, PA, 16802, USA<br/> <sup>3</sup> Institute of Pharmacology and Neuroscience Center, University of Zurich, Zurich, 8057, Switzerland<br/> <sup>4</sup> Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH), Zurich, 8057, Switzerland<br/> <p> <div class=margin-bottom> Bernhard L&uuml;scher <br/> <span>Roles: </span> Conceptualization, Project Administration, Supervision, Visualization, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Hanns M&ouml;hler <br/> <span>Roles: </span> Conceptualization, Project Administration, Supervision, Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/8-751/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 29 May 2019, 8:751 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.18758.1">https://doi.org/10.12688/f1000research.18758.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2019 Lüscher B and Möhler H. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=20548 data-id=18758 data-downloads="" data-views="" data-scholar="10.12688/f1000research.18758.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/8-751/v1/pdf?article_uuid=85d9febb-7bad-4cc1-a9e0-d3af4e7e06f8" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.18758.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Lüscher B and Möhler H. Brexanolone, a neurosteroid antidepressant, vindicates the GABAergic deficit hypothesis of depression and may foster resilience [version 1; peer review: 4 approved] <i>F1000Research</i> 2019, <b>8</b>(F1000 Faculty Rev):751 (<a href="https://doi.org/10.12688/f1000research.18758.1" target=_blank>https://doi.org/10.12688/f1000research.18758.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=18758 id=mobile-track-article-signin-18758 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/18758?target=/articles/8-751"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=20548 /> <input name=articleId type=hidden value=18758 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Jeremy Lambert</strong>, Department of Neuroscience, Division of Systems Medicine, Ninewells Hospital & Medical School, Dundee University, UK </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Rainer Rupprecht</strong>, Department of Psychiatry and Psychotherapy, University of Regensburg, Germany </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Istvan Mody</strong>, Departments of Neurology and Physiology, The David Geffen School of Medicine at UCLA, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Trevor Smart</strong>, Department of Neuroscience, Physiology & Pharmacology, University College London, UK </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (2)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class=comments-list-container> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class="mversion ">VERSION 1</span> <span class=details>PUBLISHED 29 May 2019</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <ul class=all-comment-wrapper data-reportID=NONE data-versionID=1> <li class="comment-wrapper not-sortable " data-commentID=5226> <div class="one-comment version-comments "> <a name=article-comment-5226></a> <div class="f1r-article-desk commenter-role"> Author Response 12 Feb 2020 </div> <div> <span class=name>Bernhard Luscher</span><span class=name>, </span><span class=commenter-affiliation>Pennsylvania State University, University Park, USA</span> </div> <div class="f1r-article-mobile the-comment-date"> 12 Feb 2020 </div> <div class=f1r-article-mobile> <div class="article-pubinfo-mobile comments-section"> <span class="version-info-box comments"> Author Response </span> </div> </div> <div class="comment-content article-comment-list"> <span class=truncated-comment> That is a very good question. One idea is that anxiety is caused by the primary defect in neural inhibition and the ensuing increase in network excitability, which can be ... <span class="continue-reading-container response-and-comment">Continue reading</span> </span> <span class="full-comment hidden"> <span id=full-comment-original-5226 class=hidden>That is a very good question. One idea is that anxiety is caused by the primary defect in neural inhibition and the ensuing increase in network excitability, which can be readily reversed by drugs that potentiate GABAergic inhibition. By contrast, depression appears to involve additional chronic E:I imbalance-induced homeostatic downregulation of glutamate receptors and a corresponding loss of connectivity of principal cells. Such homeostatic downregulation of glutamatergic transmission is observed in mice with constitutive defects in GABAergic inhibition (Ren et al. 2016&nbsp;Biol Psychiatry 80, 467-468) as well as when animals are exposed to chronic stress (Yuen et al Neuron 73, 962-977).(for review see Luscher and Fuchs, 2015; Adv Pharmacol 73. 97-144). Both types of defects are reversed by ketamine-induced synaptogenesis for a prolonged period (Ren et al. op cit)</span> <div class=padding-bottom id=full-comment-5226>That is a very good question. One idea is that anxiety is caused by the primary defect in neural inhibition and the ensuing increase in network excitability, which can be readily reversed by drugs that potentiate GABAergic inhibition. By contrast, depression appears to involve additional chronic E:I imbalance-induced homeostatic downregulation of glutamate receptors and a corresponding loss of connectivity of principal cells. Such homeostatic downregulation of glutamatergic transmission is observed in mice with constitutive defects in GABAergic inhibition (Ren et al. 2016&nbsp;Biol Psychiatry 80, 467-468) as well as when animals are exposed to chronic stress (Yuen et al Neuron 73, 962-977).(for review see Luscher and Fuchs, 2015; Adv Pharmacol 73. 97-144). Both types of defects are reversed by ketamine-induced synaptogenesis for a prolonged period (Ren et al. op cit)</div> <span class="disclosures competing-interests-display padding-top"> <strong>Competing Interests:</strong> <span class=c-i-d>No competing interests were disclosed.</span> </span> <span class="hide-comment-container response-and-comment">Close</span> </span> <div class="report-concern-wrapper last-comment"> <a href="mailto:research@f1000.com?subject=Report a concern (18758) " class=report-a-concern-link>Report a concern</a> </div> </div> </div> </li> <li class="comment-wrapper not-sortable " data-commentID=5131> <div class="one-comment version-comments "> <a name=article-comment-5131></a> <div class="f1r-article-desk commenter-role"> Reader Comment 23 Dec 2019 </div> <div> <span class=name>Arnold Lippa</span><span class=name>, </span><span class=commenter-affiliation>RespireRx Pharmaceuticals Inc, New Jersey, USA</span> </div> <div class="f1r-article-mobile the-comment-date"> 23 Dec 2019 </div> <div class=f1r-article-mobile> <div class="article-pubinfo-mobile comments-section"> <span class="version-info-box comments"> Reader Comment </span> </div> </div> <div class="comment-content article-comment-list"> <span class=truncated-comment> Just a brief question - How do the authors explain the ability of benzodiazepines, well known positive allosteric modulators of the GABA<sub>A&nbsp;</sub>receptors, to improve the symptoms of anxiety but not ... <span class="continue-reading-container response-and-comment">Continue reading</span> </span> <span class="full-comment hidden"> <span id=full-comment-original-5131 class=hidden>Just a brief question - How do the authors explain the ability of benzodiazepines, well known positive allosteric modulators of the GABA<sub>A&nbsp;</sub>receptors, to improve the symptoms of anxiety but not MDD?</span> <div class=padding-bottom id=full-comment-5131>Just a brief question - How do the authors explain the ability of benzodiazepines, well known positive allosteric modulators of the GABA<sub>A&nbsp;</sub>receptors, to improve the symptoms of anxiety but not MDD?</div> <span class="disclosures competing-interests-display padding-top"> <strong>Competing Interests:</strong> <span class=c-i-d>No competing interests were disclosed.</span> </span> <span class="hide-comment-container response-and-comment">Close</span> </span> <div class="report-concern-wrapper last-comment"> <a href="mailto:research@f1000.com?subject=Report a concern (18758) " class=report-a-concern-link>Report a concern</a> </div> </div> </div> </li> <li class="comment-wrapper not-sortable button-wrapper"> <div class="one-comment version-comments add-the-comment"> <a href="/login?originalPath=/articles/8-751&scrollTo=add-new-comments" class=register-report-comment-button data-test-id=add-comment> <span class=f1r-article-desk><span class=contracted></span>Comment</span> <span class="f1r-article-mobile research-layout "> <button class="primary orange extra-padding comment-on-this-article">ADD YOUR COMMENT</button> </span> </a> </div> </li> </ul> </div> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=51507-48925></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=51510-48924></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=51508-48927></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=16677-48926></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=4><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> <th class="c-report-timeline__headings-version p-article__color--dark">3</th> <th class="c-report-timeline__headings-version p-article__color--dark">4</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/8-751/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>29 May 19</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Jeremy Lambert</strong>, Department of Neuroscience, Division of Systems Medicine, Ninewells Hospital & Medical School, Dundee University, UK </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Rainer Rupprecht</strong>, Department of Psychiatry and Psychotherapy, University of Regensburg, Germany </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Istvan Mody</strong>, Departments of Neurology and Physiology, The David Geffen School of Medicine at UCLA, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Trevor Smart</strong>, Department of Neuroscience, Physiology & Pharmacology, University College London, UK </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(2)</span></p> <a class=t-h4 href="/login?originalPath=/articles/8-751&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/8-751/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Brexanolone, a neurosteroid antidepressant,...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/8-751/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/8-751/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/8-751/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Lüscher B and Möhler H');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/8-751/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/8-751",
            templates : {
                twitter : "Brexanolone, a neurosteroid antidepressant, vindicates the GABAergic.... Lüscher B and Möhler H, published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/8-751/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Brexanolone, a neurosteroid antidepressant, vindicates the GABAergic deficit hypothesis of depression and may foster resilience", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Brexanolone, a neurosteroid antidepressant, vindicates the GABAergic deficit hypothesis of depression and may foster resilience", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/18758/20548")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "20548");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "48924": 0,
                           "48925": 1,
                           "48926": 0,
                           "48927": 2,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "26d13794-5e93-4f64-b5a4-b970e56bdbc7";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/8-751.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/8-751.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/8-751.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/8-751.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/8-751.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>